Equity of Social Support and Its Relationship with Depression, Anxiety, and Antiretroviral Medication Adherence Among Seroconcordant Dyads of HIV-positive African Americans and Their Informal Supporters by Wendorf, Angela Roethel
University of Wisconsin Milwaukee
UWM Digital Commons
Theses and Dissertations
August 2014
Equity of Social Support and Its Relationship with
Depression, Anxiety, and Antiretroviral Medication
Adherence Among Seroconcordant Dyads of HIV-
positive African Americans and Their Informal
Supporters
Angela Roethel Wendorf
University of Wisconsin-Milwaukee
Follow this and additional works at: https://dc.uwm.edu/etd
Part of the Clinical Psychology Commons
This Dissertation is brought to you for free and open access by UWM Digital Commons. It has been accepted for inclusion in Theses and Dissertations
by an authorized administrator of UWM Digital Commons. For more information, please contact open-access@uwm.edu.
Recommended Citation
Wendorf, Angela Roethel, "Equity of Social Support and Its Relationship with Depression, Anxiety, and Antiretroviral Medication
Adherence Among Seroconcordant Dyads of HIV-positive African Americans and Their Informal Supporters" (2014). Theses and
Dissertations. 778.
https://dc.uwm.edu/etd/778
 EQUITY OF SOCIAL SUPPORT AND ITS RELATIONSHIP WITH DEPRESSION, 
ANXIETY, AND ANTIRETROVIRAL MEDICATION ADHERENCE AMONG 
SEROCONCORDANT DYADS OF HIV-POSITIVE AFRICAN AMERICANS AND 
THEIR INFORMAL SUPPORTERS 
 
 
by 
 
Angela R. Wendorf 
 
A Dissertation Submitted in 
Partial Fulfillment of the  
Requirements for the Degree of 
 
Doctor of Philosophy 
in Psychology 
 
at 
The University of Wisconsin-Milwaukee 
August 2014 
 
 
 
 
 
  
i 
 
ABSTRACT 
EQUITY OF SOCIAL SUPPORT AND ITS RELATIONSHIP WITH DEPRESSION, 
ANXIETY, AND ANTIRETROVIRAL MEDICATION ADHERENCE AMONG 
SEROCONCORDANT DYADS OF HIV-POSITIVE AFRICAN AMERICANS AND 
THEIR INFORMAL SUPPORTERS 
 
by 
Angela Wendorf 
The University of Wisconsin-Milwaukee, 2014 
Under the Supervision of Professor Katie Mosack 
 
Social support may be an important resource for those coping with stigmatized chronic 
illnesses, such as HIV/AIDS,  as social support may buffer the deleterious impact of 
HIV-related distress (Derlega, Winstread, Oldfield, & Barbee, 2003; Stutterheim, Bos, 
Pryor, Brands, Liebregts, & Schaalma, 2011; Ueno & Adams, 2001). Yet little is known 
about characteristics of social support among HIV-positive patients in relationships with 
other HIV-positive individuals and whether there is an equivalent perception and 
provision of support between each patient in the relationship. To examine how equity of 
support within the dyad may contribute to nuances in social support, mental health 
outcomes, and treatment adherence among HIV-positive individuals, I recruited 34 dyads 
comprised of HIV-positive African Americans and their HIV-positive supporters to 
complete a survey with measures of perceived social support, equity of support, 
relationship factors such as perceived quality of the relationship, depression and anxiety, 
and treatment adherence. The results indicate that perceptions of greater perceived social 
support from one’s dyadic partner was associated with fewer depressive or anxiety 
symptoms. Index patients and informal supporters’ perceptions of source- specific social 
support were not related to index patients’ past month medication adherence. 
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Participants’ own and dyad partners’ perceptions of equity (i.e., deviation from equity) 
were not identified as significant predictors for any of the outcome variables. There was 
no evidence of significant partner effects for any of the study hypotheses. Thus, the 
results from this study may be most consistent with an actor-oriented model (Kenny & 
Cook, 1999), wherein the participants’ outcomes are a function of the individuals’ 
perceptions themselves, and their partners’ perceptions have no effect on the individuals’ 
outcomes. The results from this study indicate the protective effects of individuals’ 
perceptions of being supported by a specific support person, generalized among a variety 
of relationships, on depressive and anxiety symptoms. Future research should explore the 
perceptions of support and the rules that may govern relationships among individuals in 
HIV-affected relationships to better understand the nuances in social support and their 
relation to mental health and treatment outcomes.  
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Equity of Social Support and its Relationship with Depression, Anxiety, and 
Antiretroviral Medication Adherence among Seroconcordant Dyads of HIV-Positive 
African Americans and their Informal Supporters   
 
The experience of having a chronic and life-threatening illness can present 
considerable psychological challenges related to the trauma of the diagnosis, resultant 
physical and functional impairments, and threats to health (Dunlop et al., 2004). In the 
case of HIV/AIDS, patients may also be likely to grapple with issues such as responding 
to stigma and discrimination, negotiating sexual relationships, and dealing with 
uncertainty related to health and medication effectiveness. Patients are also managing 
aversive short- and long-term medication side effects (e.g., diarrhea, neuropathy, 
lipodystophy, liver disease, and so forth) while being reminded of the need for long-term 
medication usage and strict medication adherence to prolong survival. Consequently, 
HIV-positive patients are at increased risk for the development of depressive disorders 
(Ciesla & Roberts, 2001). Similarly, HIV-positive patients may be at risk for the 
development of anxiety disorders, particularly if they have not developed adaptive coping 
strategies to deal with HIV-related distress and uncertainty (O’Cleirigh, Hart, & James, 
2008).One of the prominent self-care strategies for coping with HIV-related stress and 
managing depressive symptoms and anxiety endorsed by HIV-positive patients is seeking 
social support from others (Eller et al., 2005; Eller et al., 2010; Kemppainen et al., 2003; 
Kemppainen et al., 2006; Kemppainen et al., 2012; Tufts, Wessel, & Kearney, 2009). 
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Social Support in the Context of HIV 
Social support is conceptualized as interpersonally-provided aid in terms of 
emotional, self-esteem, informational, instrumental, and financial resources and 
assistance (Berkman, Glass, Brissette, & Seeman, 2000). Although several types of social 
support have been proposed in the literature, there are five primary types of social 
support that have gained consensus. As described by Cutrona and Suhr (1994; 120) the 
primary types of social support include informational support, tangible aid, emotional 
support, social network support, and esteem support. The authors describe Informational 
Support as “providing information about the stress itself or how to deal with it;” (pg.120) 
an example of informational support could be the provision of information by the 
patient’s medical doctor for different ways to cope with HIV medication side effects. 
Receiving financial assistance from a family member for medical bills would be an 
example of Tangible Aid, defined by the authors as “providing or offering to provide 
goods or services needed in the stressful situation” (pg. 120). The authors describe 
Emotional Support as “communicating love, concern, or empathy” (pg. 120), thus; when 
others affirm their love for the patient they are providing emotional support. On the other 
hand, Social Network Support, or “communicating belonging to a group of persons with 
similar interests or concerns” (pg. 120) might be expressed when a supporter shares 
examples of others who have successfully remained adherent to HIV medications. 
Finally, when a supporter emphasizes their HIV-positive loved one’s self-worth through 
“communicating respect and confidence in abilities,” they are demonstrating Esteem 
Support (Cutrona & Suhr, 1994, pg. 120). 
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Social support may be an important resource for those coping with stigmatized 
chronic illnesses. Social support provided by individuals in the patient’s social network 
(i.e. informal supporters) has been proposed to influence the patient’s illness 
representation, the process of adjustment to illness, experience of symptoms, 
management of symptoms, and adherence to medications (Spirig, Moody, Battegay & De 
Geest, 2005). In the context of HIV, social support has been shown to buffer the 
deleterious impact of HIV-related distress on individuals’ psychosocial functioning 
(Derlega, Winstread, Oldfield, & Barbee, 2003; Stutterheim, Bos, Pryor, Brands, 
Liebregts, & Schaalma, 2011; Ueno & Adams, 2001). Furthermore, social support can be 
used to manage uncertainty associated with the experience of HIV/AIDS (Brashers, 
Neidig, & Goldsmith, 2004), assist with antiretroviral medication adherence efforts 
(Hamilton, Razzano, & Martin, 2007; Stumbo, Wrubel, & Johnson, 2011), and instill 
hope in patients (Harris & Larsen, 2007).  
Social support may be an especially relevant resource for HIV-positive African 
Americans who are disproportionately affected by the disease. For instance, although 
African Americans comprise 14% of the population, they make up 46% of the HIV-
positive population living in the United States, which is an estimated 1.2 million people 
(Centers for Disease Control and Prevention [CDC], 2011). Furthermore, African 
Americans account for 44% of new HIV infections each year (CDC, 2011). In fact, 
African Americans represent the greatest proportion of cases of HIV-positive women, 
heterosexual men, injection drug users, and infants (CDC, 2007). Disparities in the 
distribution of power and resources and resulting social inequalities that are particularly 
prevalent in the African American community (e.g., poverty, decreased access to health 
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care, lack of insurance, incarceration) may significantly contribute to increased rates of 
HIV infection, poorer health outcomes, fewer coping resources, and increased rates of 
emotional distress among African Americans living with HIV/AIDS (Davidson, 2011; 
Zierler & Krieger, 1997).  
Seeking social support has been identified as a primary self-care behavior among 
African Americans living with HIV (Tufts, Wessell, & Kearney, 2009). Support from 
others coping with HIV/AIDS may be particularly helpful for patients because of the 
social isolation, stigma, and discrimination that people living with HIV/AIDS may 
experience (Coates et al., 1987). Peer support has been shown to be an important resource 
for coping with HIV and can be even more helpful than family support (Adelman & Frey, 
1997; Spirig, 1998; Brashers, Neidig, & Goldsmith, 2004), because people may perceive 
friends as being more helpful than family (Serovich, Kimberly, Mosack, and Lewis, 
2001). People living with HIV turn to peers for informational support, advocacy, 
emotional support, and understanding. Peer support has also been found to facilitate skills 
for decision-making and advocating for one’s own health care (Brashers, Haas, Klingle, 
& Neidig, 2000; Brashers, Neidig, & Goldsmith, 2004). 
Social Support and Depression 
Associations between the lack of positive social support and the presence of 
unsupportive interactions with depression among HIV positive individuals are evident in 
the literature (Siegel, Ravhis, & Karus, 1994, 1997; Ingram et al., 1999; Hays, Turner and 
Coates, 1992; Serovich et al., 2001). Among individuals living with HIV/AIDS, the 
presence of social support has been associated with fewer depressive symptoms (Ingram 
et al., 1999; Metts, Manns, & Kruzic, 1996; Siegel, Karus, & Raveis, 1997). Research 
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indicates that perceived and enacted HIV-related social support is inversely associated 
with depressive symptoms among HIV-positive women and men, such that lower levels 
of actual or perceived support are consistently associated with higher frequency or 
severity of depressive symptoms (Carrieri et al., 2003; Fukinishi et al., 1997; Heckman et 
al., 2004; Rabkin et al., 1997; Simoni, Huang, Goodry, & Montoya, 2006; Turner, Hays, 
& Coates, 1993). Additionally, some researchers have found that perceived social support 
has a stronger inverse association with depressive symptoms than enacted support 
(McDowell & Serovich, 2007). Being satisfied with the quality of social support has been 
associated with a decreased likelihood of depression (Hays, Turner, & Coates, 1992, 
Ingram et al., 1999). On the other hand, negative or unsupportive interactions have been 
linked with depression among HIV-positive individuals. In a sample of 271 people living 
with HIV, Ingram et al., (1999) identified three types of unsupportive interactions 
associated with depression; insensitivity, disconnecting, and blaming. Depression may 
also create strain and stress in interpersonal relationships within this context, making it 
more difficult to obtain continued support from others, resulting in a diminished quality 
of support received from others (Knowlton, Curry, Hua, & Wissow, 2009; Schrimshaw, 
2002). Consequently, depressive symptoms could be exacerbated if the person living with 
HIV/AIDS experiences a loss of support, completing a vicious cycle of diminishing 
support and increasing depressive symptoms.  
Social Support and Anxiety 
  Compared to the literature on social support and depression, there has been 
considerably less research conducted on the topic of social support and anxiety. Among 
individuals living with HIV/AIDS, the most prevalent anxiety-related disorders are 
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adjustment disorders with anxiety, generalized anxiety disorder, and posttraumatic stress 
disorder (Kerrihard et al., 1999; Kessler et al., 2005). Low partner support has been 
identified as a potential predictor of the development of adjustment disorder with anxiety 
in HIV-positive men, along with a history of generalized anxiety, and a coping style 
characterized by low mastery or control over life events (Dew et al., 1997). More 
recently, researchers have examined the differential effects of social support by support 
providers on anxiety symptoms for people living with HIV/AIDS. Gordillo and 
colleagues (2009) found that emotional support from family and friends has been 
associated with lower levels of anxiety symptoms among HIV-positive men and women 
living with HIV, but emotional support from partners was not significantly associated 
with anxiety. 
Most research examining social support and anxiety has been focused on the 
realm of fear and anxiety symptom management (Kemppainen et al., 2003; Kempainnen 
et al., 2006; Kemppainen et al., 2012) and has included cross cultural samples of people 
living with HIV/AIDS in Kenya, South Africa, Norway, Taiwan, and the United States. 
Kemppainnen and colleagues (2003) examined perceived causes of anxiety symptoms 
and fearfulness among 73 HIV-positive individuals in the United States who reported 
anxiety as their most troublesome HIV-related symptom. Participants attributed their 
anxiety symptoms and fears to concerns about the personal or existential impact of HIV 
(i.e., concerns about being HIV positive, concerns about how the virus was contracted, 
worry about HIV as a punishment, concerns about treatments; worry about changing 
physical appearance; concerns about the future, fears about death); social relationships 
and HIV (i.e., worry about contagion, disclosure, discrimination, losses, concerns about 
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the impact HIV has on the family, fearing the responses of healthcare providers; and 
concerns related to structural issues (i.e., economics and housing). The most frequent 
causes of fear and anxiety were concerns about death and worries about the future 
(Kemppainnen et al., 2003). HIV-related death anxiety, a prominent fear described above 
and related to death due to HIV illness, has been shown to be modestly and inversely 
associated with social support in a recent meta-analysis of 18 studies examining death 
anxiety in people living with HIV/AIDS (Miller, Lee, & Henderson, 2012). Thus, social 
support appears to have a modest protective effect for the presence of death anxiety.  
Seeking social support is a common strategy for the management of HIV-related 
fear and anxiety. For instance, in the study conducted by Kemppainen et al. (2003), 21% 
of the 73 participants reporting anxiety as their most troublesome HIV-related symptom 
in the study reported seeking advice from supportive family members, friends, medical 
providers, and HIV-positive peers to cope with anxiety. In a more recent study conducted 
by Kemppainen and colleagues (2012), 343 HIV-positive participants from Kenya, South 
Africa, and the United States endorsing anxiety as a prominent HIV-related symptom, 
reported utilizing social support self-management strategies, including talking with 
family and friends (n=199, 58.0%); talking with others (n=144, 42%), and attending a 
support group (n=83, 24.2%). Among 502 HIV-positive individuals from Norway, 
Taiwan, and the United States who endorsed anxiety as a prominent HIV-related 
symptom reported talking with family and friends as a strategy to manage their anxiety 
(n=398, 58.25 daily, 32.7% monthly). However, talking with family and friends was only 
rated as a moderately effective self-care behavior for anxiety among this sample 
(Kemppainen et al., 2006). It is unclear what aspects of seeking support from family and 
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friends were beneficial and which were less advantageous for management of anxiety 
symptoms.  
Social Support and Adherence 
Evidence suggests that limited social support (Ammassari et al., 2002; Catz et al., 
2000; Fogarty et al., 2002; Machtinger & Bangsberg, 2005) and less stability of social 
support is associated with non-adherence to HIV medications (Johnson et al., 2003). On 
the other hand, researchers have found that the presence of positive social support is 
related to adherence (Cox, 2009; Gonzalez, et al., 2004; Murphy et al., 2004; Remien et 
al, 2003) and satisfaction with social support is related to greater adherence (Vyavaharkar 
et al., 2007). Conversely, less stability of social support has been associated with non-
adherence to HIV medications (Johnson et al., 2003).  
The relationship between social support and adherence may, however, be more 
complex than some have demonstrated. For instance, the nature of the relationship 
between the support provider and recipient may have differential effects on the 
perception of support by the recipient (Johnson et al., 2003; Schwarzer, Dunkel-Schetter, 
& Kemeny, 1994; Serovich et al., 2001). Individuals with HIV report perceiving more 
social support from partners or friends than from family members (Johnson et al., 2003; 
Schwarzer, Dunkel-Schetter, & Kemeny, 1994; Serovich et al., 2001). There are also 
complex results when types of relationships, supporter factors (such as HIV status), 
characteristics of support, and medication adherence have been examined. For example, 
contrary to the general finding that support is predictive of adherence, some have found 
that having a primary partner is actually predictive of non-adherence (Johnson et al., 
2003; Knowlton et al., 2011).  
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Recently there has been increased attention on the examination of couple-level 
variables associated with HAART adherence (Knowlton et al., 2011; Johnson, Dilworth, 
Taylor, Darbes, Comfort, & Neilands, 2011). For instance, Knowlton and colleagues 
(2011) examined main partner factors associated with adherence to HAART among a 
diverse, primarily African American, population of HIV-positive women in Baltimore 
and found that medication adherence rates differed drastically between those without a 
partner, those with a seronegative partner, and those with a seropositive partner. 
Specifically, rates of HAART adherence (self-reported past seven day recall) were 
highest (i.e., 92%) for non-partnered women and lowest (i.e., 57%) among those in 
seroconcordant relationships, i.e., those in which both members of the couple are HIV-
positive. Results from adjusted analyses indicated that “better” (e.g., greater than 90%) 
medication adherence was 75% less likely among women in seroconcordant 
relationships; moreover, better medication adherence was 78% less likely among women 
who relied on their HIV-positive partner for emotional support. Additional analyses 
revealed that there was a discrepancy with support needs and support receipt among 
women with partners. Overall, 53% of HIV-positive women with either a seropositive or 
seronegative partner reported preferences of receiving the most emotional support from 
partners; however, only 35% indicated that their partner was indeed their main supporter. 
The discrepancy was even greater among women with a seropositive partner (i.e., in 
seroconcordant relationships), with 68% of women reporting preferences for their partner 
as their main HIV-supporter, and only 32% receiving main HIV-related support from 
their partner. Thus, support needs did not appear to be met among this sample of HIV-
positive partnered women, particularly among those in seroconcordant relationships.   
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When support is enacted by informal supporters, people living with HIV describe 
the types of emotional and instrumental support that they receive with respect to 
medication adherence, such as coaching, providing medication reminders, monitoring 
medication adherence, filling prescriptions, and assisting with medication administration 
(Wrubel et al., 2008). Behaviors that are perceived as helpful include those that 
demonstrate empathy and teamwork or partnership and behaviors that are perceived as 
unhelpful include when support attempts seem intrusive, insincere, dismissive, or 
avoidant (Barbee, Derlega, Sherburne, & Grimshaw, 1998; Mosack & Petroll, 2009). 
Patients and health care providers have described what this looks like in the HIV/AIDS 
health care context when informal supporters attend medical appointments; examples 
given for unhelpful support attempts include when the treatment supporter nags the 
patient or dominates discussions with health care providers (Mosack & Petroll, 2009; 
Mosack & Wendorf, 2011). Even supportive behaviors that informal supporters perceive 
to be in the interest of the recipients’ treatment adherence may not be. For instance, Beals 
and colleagues (2006) found that caregivers’ reminding HIV-positive patients to take 
medications was not significantly associated with medication adherence. Taking these 
findings into account, researchers have hypothesized that it may be the unhelpful 
interactions between partners that contribute to poor rates of medication adherence 
(Johnson et al., 2003).  
In summary, although the extant literature on social support in the context of HIV 
has largely documented positive associations between social support and positive 
physical and mental health outcomes, the mechanisms linking social support with 
physical and mental health outcomes and the ways in which social support might 
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contribute to negative outcomes remain unclear. Part of the problem may be because 
there is an insufficient emphasis on the underlying dimensions of social support; in 
particular, on social exchanges (i.e., giving and receiving support) within supportive 
relationships. However, it is important to note that there has been scant exploration of the 
dimensions of support and exchange of support for individuals in HIV-affected 
relationships outside of the context of partnerships; that is, for those in HIV-affected 
supportive relationships irrespective of romantic, conjugal, or other familial ties. Indeed, 
there are gaps in the literature on social support in the context of broad HIV-affected 
relationships, particularly on the transactional nature of social support as related to 
mental health and treatment adherence (Wrubel, Stumbo, & Johnson, 2008; Knowlton et 
al., 2011). Researchers have hypothesized that unhelpful interactions between partners 
may contribute to poor rates of medication adherence (Johnson et al., 2003). However, 
the parity of support exchanged in the relationship has not yet, to my knowledge, been 
examined in the context of broad seroconcordant HIV-affected relationships. Thus, little 
is known about whether there is equivalent receipt and provision of support between each 
HIV-positive patient in the relationship.  
Equity of Social Support in Relationships 
Equity theory suggests that close relationships incorporate a balance of “give and 
take” between members of the relationship, and that an imbalance in the support provided 
and received is associated with dissatisfaction and negative psychological consequences. 
According to this theory, then, an imbalance in support provided and received in the 
relationship can have negative psychological consequences such as guilt or 
demoralization and can create perceptions of debt or obligation within a relationship due 
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to violations of the norm of reciprocity of support (Walster, Walster, & Bersheid, 1978; 
Gleason, Iida, Bolger, & Shrout, 2003; Kleiboer, Kuijer, Hox, Schreurs, & Bensing, 
2006).  
There may be differential psychosocial and emotional consequences based on the 
way that individuals within relationships perceive their overbenefitting or 
underbenefitting from the support exchange. For instance, when individuals receive more 
support than that which they provide (e.g., overbenefitting), they may feel guilty, too 
dependent on others, and incompetent to deal with stressors (Liang, Krause, & Bennett, 
2001; Lindorff, 2000; Lu & Argyle, 1992) while those providing more support than 
receiving (e.g., underbenefitting) may become resentful or experience decreased morale 
(Liang, Krause, & Bennett, 2001). Having mutual exchange of support in relationships, 
which influences perceptions of equity, has been associated with positive perceptions of 
support and better physical and mental health outcomes compared to those with non-
reciprocal support in their relationships (Chandola, Marmot, & Siegrist, 2007). Results 
from qualitative research conducted with HIV-positive gay couples provide evidence of 
participants’ viewing their relationships as more supportive and satisfactory when the 
support is balanced between partners and they have opportunities to give and receive 
support (Haas, 2002).In an early study exploring opportunities to provide support to 
supporters, Hays and colleagues (1990) found that the degree to which HIV-positive gay 
men endorsed giving support to members of their social support network was strongly 
correlated with their psychological well-being. Qualitative analyses of interview data 
from the same study revealed that being able to give support to social network members 
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was identified as a helpful support behavior, and that participating in peer support groups 
provided an important opportunity to provide support (Hays, Magee, & Chauncey, 1998).  
When patients or informal supporters are coping with a chronic illness such as 
HIV, the patient’s health status and support needs may influence the balance of support in 
their relationships. Indeed, equity of support has been examined in the context of health 
status, though to my knowledge not in the context of HIV health status. In general, those 
with poorer health status who require more caregiving or support, such as patients in 
palliative care, may perceive that they are overbenefitting from support (McPherson, 
Wilson, & Murray, 2007). What is unclear, however, is the relationship between health 
status and perceptions of differential benefit among those in close relationships in which 
both members of the relationship are dealing with an illness such as HIV or AIDS, 
considering that care and other forms of support are exchanged between members of the 
relationship who are each dealing with a complex illness.  
An examination of equity of support (and, conversely, deviation from equity of 
support) may help to better explain complex associations between perceived social 
support, mental health, and treatment adherence among HIV-positive individuals in close 
relationships with other people living with HIV/AIDS. Furthermore, it is important to 
examine these issues because an improved understanding of social support mechanisms 
contributing to emotional adjustment and treatment adherence could reveal areas for 
intervention to affect change at individual (e.g., mental health) and interpersonal levels of 
functioning (e.g., communication, interpersonal effectiveness) and address relationship 
and treatment adherence issues for HIV-positive individuals supporting others living with 
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HIV/AIDS. Results of the present study may be able to lay the groundwork for 
development of psychosocial interventions for HIV-positive persons and their supporters.  
Present Study 
The purpose of the present study was to examine the relationship between equity 
and perceived social support with variables including depression, anxiety, medication 
adherence, and disease status among seroconcordant dyads of African Americans and 
their informal supporters. The present study will draw from populations with a high 
burden of HIV. Wisconsin state surveillance reports indicate that 57% of HIV/AIDS 
cases are concentrated in Milwaukee County, with 75% of African American HIV cases 
being located in Milwaukee County. Significant racial and ethnic disparities exist in 
terms of prevalence and risk factors for HIV, with the African American community 
being hardest hit by the epidemic. For example, from 2007-2011 in the state of 
Wisconsin, African American males were 5-10 times more likely to be diagnosed with 
HIV than Caucasian males; while African American women were more than 25 times 
more likely to be diagnosed with HIV than Caucasian women. For persons aged 15-29, 
77% of cases were African American, and for those 30 or older, 51% of cases were 
African American (Wisconsin Department of Health Services AIDS/HIV Program, 
2010). Furthermore, recent data indicates that there is extremely high prevalence of HIV 
among African American males who have sex with men (MSM) in Wisconsin, with one-
in-three or 32% of African American MSM being HIV positive (Wisconsin Department 
of Health Services AIDS/HIV Program, 2012). A high burden of HIV also exists for 
African Americans in Ohio. In 2009, African American adults were 6 times as likely to 
be diagnosed with HIV compared to Caucasian adults. African American males were 
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approximately 5 times more likely to be living with HIV than Caucasian males, while 
African American women were more than 12 times as likely to be living with HIV 
compared to Caucasian women (Ohio Department of Health, 2011). In Columbus, Ohio 
located in Franklin County, African Americans accounted for 36% of the cases of 
individuals living with HIV infection. When the fact that African Americans comprise 
only 12% of the state population (Ohio Department of Health, 2011) is taken into 
account, the stark disproportionality of the HIV epidemic is evident.      
This study has the following specific aims and research goals: (1) To examine 
whether equity of support, or perceived equality of support, within seroconcordant dyads 
predicts depression, anxiety, and medication adherence above and beyond perceived 
social support; and (2) to examine how mismatch in disease status among members of the 
dyad (e.g., HIV-positive, no AIDS diagnosis and HIV-positive, AIDS diagnosis) may 
predict equity of support, depression, and anxiety among the dyad members. In line with 
these aims, I tested several hypotheses to examine associations between variables of 
interest and to test prospective models of relations between variables. My specific 
hypotheses follow: 
Model 1:  Perceived Social Support, Support Equity and Medication Adherence 
 
Hypothesis 1: Actor Effects 
 
1. It is hypothesized that greater levels of actor perceived social support and 
greater actor equity (lower deviation from equity) will be associated with 
greater rates of medication adherence. 
Hypothesis 2: Partner Effects 
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2. It is hypothesized that higher levels of partner perceived social support will be 
associated with higher rates of index patient medication adherence and greater 
partner equity (lower deviation from equity) will be associated with higher 
rates of medication adherence. 
Hypothesis 3: Model Fit 
 
3. It is hypothesized that actor and partner equity of support (as measured by 
deviation from equity) will predict medication adherence above and beyond 
perceived social support from the dyad partner.  
Model 2:  Perceived Social Support, Equity, and Depressive Symptoms 
 
Hypothesis 4: Actor Effects 
 
4. It is hypothesized that higher levels of actor perceived social support and 
greater actor equity (lower deviation from equity) will be associated with 
lower actor severity of depressive symptoms. 
Hypothesis 5: Partner Effects 
 
5. It is hypothesized that higher levels of partner perceived social support and 
greater partner equity (lower deviation from equity) will be associated with 
lower actor severity of depressive symptoms. 
Hypothesis 6: Model Fit 
 
6. It is hypothesized that actor and partner equity of support (as measured by 
deviation from equity) will predict severity of depressive symptoms above and 
beyond perceived social support from the dyad partner.  
Model 3:  Perceived Social Support, Equity, and Anxiety Symptoms 
 
Hypothesis 7: Actor Effects 
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7. It is hypothesized that greater levels of actor perceived social support and 
greater actor equity (lesser deviation from equity) will be associated with 
lower actor severity of anxiety symptoms. 
Hypothesis 8: Partner Effects 
 
8. It is hypothesized that greater levels of partner perceived social support and 
greater partner equity (lesser deviation from equity) will be associated with 
lower actor severity of anxiety symptoms. 
Hypothesis 9: Model Fit 
 
9. It is hypothesized that actor and partner equity of support (as measured by 
deviation from equity) will predict severity of anxiety symptoms above and 
beyond perceived social support from the dyad partner.  
Model 4:  AIDS Status Concordance, and Equity, Depressive and Anxiety 
Symptoms 
 
Hypothesis 10: Between-Dyads Variable Predictions 
 
10. It is hypothesized that discordant dyad AIDS status (i.e., one partner has a 
diagnosis of HIV and the other has a diagnosis of AIDS, representing greater 
disease progression) will be associated with greater inequity (greater deviation 
from equity), greater severity of depressive symptoms, and greater severity of 
anxiety symptoms. 
Significance of the Present Study 
This study will enable us to better understand the social support mechanisms 
which contribute to mental health outcomes and treatment adherence. Once we have a 
better understanding of the social support mechanisms that contribute to improved 
adherence, we will have a better idea of how to address salient relationship and treatment 
18 
 
 
 
adherence issues for HIV-positive individuals supporting others living with HIV/AIDS, 
and be better able to utilize social support in HIV adherence interventions. Moreover, 
being able to effect change in treatment adherence over time has the potential to redress 
racial disparities in HIV health and health care (Mugavero et al, 2009).  
Methods 
Design 
 
This study was considered a cross-sectional reciprocal standard design, as both 
members of the dyad were measured and each person is a member of only one dyad. This 
design allows for the assessment of the variability in responding both between and within 
dyads in the present study. Further, the analyses used in the present study allow for the 
simultaneous and independent estimation of the effects of each participant’s self report on 
both his or her own behavior and their dyad partner’s behavior (Campbell & Kashy, 
2002).  
Participants 
 
Participants were 34 HIV-positive African American individuals (i.e., “index 
patient”) and 34 HIV-positive adults (e.g., partners, family members, or friends; i.e., 
“informal supporters”) from Milwaukee, Wisconsin; Chicago, Illinois; and Columbus, 
Ohio. My sample was drawn from high prevalence populations for HIV/AIDS in these 
urban locations.  
Specific inclusion criteria for the “index patient” include age 18 or older, being 
African American, having an HIV diagnosis, being currently prescribed antiretrovirals, 
and that they can identify and successfully recruit an adult “informal supporter” who is 
also HIV-positive, already aware of the index patient’s HIV status, and who has already 
discussed HIV and/or HIV medications with the “index patient.” Inclusion criteria for 
19 
 
 
 
“informal supporters” include being 18 or older, having an HIV diagnosis, and self-
identification as an “informal supporter” for the HIV-positive “index patient.” Only the 
index patient member of the dyad must have been African American; the informal 
supporter may have been of any ethnicity. Furthermore, dyads did not need to be 
romantically involved and I intended to enroll individuals in a broad variety of supportive 
relationships. Exclusion criteria included solitary individuals and dyads in which English 
was not spoken. Specific exclusion criteria pertaining to the participants’ relationship 
included dyads in which there is evidence that the relationship was not a legitimate one 
(i.e., information about the type or length of relationship was inconsistently reported by 
members of the dyad) or which was not intimate enough (i.e., the members do not talk 
regularly), or those in which either individual reported relational violence within that 
dyad. 
To estimate the sample size required to detect statistically significant differences 
in dependent variables consistent with the aims of the study, adequate power to detect 
consequential nonindependence must be determined. Consequential nonindependence is 
defined as the level at which the intraclass correlation associated with nonindependence 
results in a p-value of .10 when it should equal .05 (e.g., a Type I error). The minimum 
number of dyads to have adequate power of .80 to detect consequential non-
independence is 35 dyads (Kenny, Kashy, & Bolger, 1998), using a recommended liberal 
alpha test value (α=.20, two-tailed; Myers, 1979). As an estimation of the power to detect 
statistically significant differences in dependent variables in the study, Kenny, Kashy, 
and Cook (2006, p. 180) have indicated that a sample size of 50 dyads may result in a 
medium effect size of .5 with power of .64 (adjusted for nonindependence) or .697 
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(unadjusted for nonindependence). Taking into consideration concerns about feasibility, a 
sample size of 50 dyads was targeted for the pilot study. Due to difficulties obtaining 
eligible participants, my sample size is restricted to 34 dyads, which should result in the 
ability to detect a large effect size.     
Procedure 
 
Institutional Review Board approval was obtained for all aspects of the proposed 
study. Participants were recruited from outpatient infectious disease clinics, community 
health centers, and community-based agencies providing services to patients with 
HIV/AIDS in three Midwestern urban cities, Milwaukee, Wisconsin; Chicago, IL; and 
Columbus, Ohio. Recruitment strategies included distributing fliers and handbills, 
recruiting through medical provider word of mouth (i.e., discussing study opportunities 
with patients and colleagues), and snowball sampling. Potential participants were invited 
to call the Patient Advocacy and Research lab at UW-Milwaukee for more information 
about the study. After contacting the lab, they were screened over the phone for inclusion 
in the study. Participants who identified one individual who would be an appropriate 
“informal supporter” for the study and who met other eligibility requirements were 
instructed to have the intended informal supporter call the same number in order to also 
be screened. Each potential participant was screened separately to determine whether the 
dyad was eligible for participation.  
Dyads who met eligibility criteria were invited to take part in a larger mixed 
methods study, the duration of which was approximately 2 ½ hours. Participants were 
asked to bring their HIV medication along to their appointment. During this one-time 
visit, dyads were asked to come to a community research center in downtown 
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Milwaukee; Chicago, IL; or Columbus, Ohio to complete a self-report psychosocial 
survey (approximately 1 ½ hours in length) and an observed communication task 
(approximately 30 minutes in length). The survey included questions related to 
demographics, treatment adherence, medication adherence self-efficacy, problem-solving 
styles, perceived and enacted social support, equity of support, depression symptoms, and 
symptoms of anxiety. They were also asked to complete a brief debriefing questionnaire 
following the communication task and participate in a brief follow-up phone call in 
which they were asked to answer a single survey question. For the purposes of this study, 
I analyzed survey responses exclusively. For this survey, the “index patient” and the 
“informal supporter” completed identical questionnaires which took approximately 90 
minutes to complete.  
Questionnaire data were collected on individual, password-protected laptops 
using the ACASI (Audio Computer Administered Self Interview) module of QDS 
Questionnaire Development System (NOVA Research Company). Survey data was 
exported from the QDS survey instrument to a password-protected computer in the 
Patient Advocacy and Research Lab. Participants were each paid $30 for their time 
following the completion of the study appointment. In addition, child care, bus fare, and 
refreshments were available to participants as warranted. Participants received 
transportation compensation even if they did not complete the study.  
Approximately one week after the completed study appointment, one participant 
in each dyad was randomly selected and contacted to answer a follow-up survey question. 
The purpose of the follow-up question was to examine test-retest reliability of the equity 
survey item corresponding with hypotheses one, two, three, and four.  Research staff 
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contacted the participant at the number provided on the consent from and asked them the 
follow up question over the phone. Participation in this component took approximately 
one minute and participants did not receive any additional compensation for their 
participation. Not more than one participant from each dyad was contacted to respond to 
this item and only a subset of those who consented to this procedure were contacted. 
Materials and Measures 
Demographics. Participants were asked to answer basic sociodemographic and 
relationship questions including the nature of the relationship between individuals in each 
dyad. Specifically, participants reported their age, gender, current relationship status, 
race/ethnicity, highest level of education completed, gross monthly income, and number 
of children they have. In addition, they reported HIV-related demographic information 
such as HIV status, where diagnosed with HIV, year of diagnosis, believed method of 
HIV infection, HIV-related services received, most recent CD4 and viral load count, and 
HIV-related health care appointment attendance.  
Perceived Social Support. To measure participants’ degree of perceived social 
support, the Social Provisions Scale (Cutrona & Russell, 1987) was used. Participants 
completed both the original (general) questionnaire which asks participants to consider 
the degree of social support they perceived in general and the targeted source-specific 
questionnaire. For the purposes of this study, only data from the target-specific social 
support questionnaire was used, modified for use in the current study by having the target 
identified as their dyad partner. On the questionnaire, participants were asked to consider 
the degree of support they perceive from the person who accompanied them to the 
appointment (i.e., the other member of the dyad). The respondent indicated on a 4-point 
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Likert-type scale the extent to which each statement describes his/her current social 
network. Responses ranged from 1 (strongly disagree) to 4 (strongly agree). A total score 
was computed by summing all items. Higher scores indicate a greater degree of perceived 
support. With regard to the validity of the Social Provisions scale, there is good evidence 
of discriminant, predictive, and convergent validity (see Cutrona & Russell, 1987; 
Russell & Cutrona, 1984).  
There is evidence for good convergent validity and acceptable internal 
consistency reliability for the Source-Specific Social Provisions scale (Cutrona, 1989).  
For this study, internal consistency for the Source-Specific Social Provisions scale was 
good with α=.85. For the purposes of my analyses, source-specific perceived social 
support (Source-Specific Social Provisions Total Score) was treated as a predictor 
variable to test hypotheses 1-9 and as an outcome variable as a test of hypothesis 10. 
Equity. To assess equity of support in the dyadic relationship, a one-item measure 
modified from Kuijer, Buunk, & Ybema (2001), which was based on the Hatfield Global 
Measure of Equity/Inequity (Hatfield, 1978), was used. The item was intended to 
measure the equality of support from a give-and-take perspective within the dyad. The 
original item used by Kuijer et al. (2001) read, “When you look at your relationship with 
your partner, from a viewpoint of give-and-take, how would you describe your 
relationship at the moment? The original 5-pt response scale ranged from (1) S/he is 
doing a lot more for me I am doing for him/her to (5) S/he is doing a lot less for me than I 
am doing for him/her. The item used in this study was modified from Kuijer et al. (2001) 
to change the wording from “partner” to “person you came in with today” in order to 
reflect the broad nature of relationships among dyads that were recruited.  Two anchor 
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points were added to the scale, based on personal communication with R. Kuijer (2011) 
and to be consistent with the 7-point scale construction of the original Hatfield Goblabal 
Measure of Equity/Inequity from which the measure was originally modified. The anchor 
points that were added to the scale was “more” and “less”. The actual item in my study 
read, “When you look at your relationship with the person you came in with today, from 
a viewpoint of give-and-take, how would you describe your relationship at the moment?” 
Participants endorsed one of the following options (based on personal communication 
from Kuijer et al., 2001), (1) S/he  is doing a lot more for me than I am doing for him/her; 
(2) S/he  is doing more for me than I am doing for him/her; (3) S/he  is doing a bit 
more for me than I am doing for him/her; (4) S/he is doing as much for me as I am doing 
for him/her; (5) S/he is doing a little less for me than I am doing for him/her; (6) S/he  is 
doing less for me than I am doing for him/her; (7) S/he is doing a lot less for me than I 
am doing for him/her. Consistent with Kuijer, Buunk, and Ybema’s (2001) 
recommendations, anchor points are recoded for data analyses in such a way that 1 = +3, 
2 = +2, 3 = + 1, 4 = 0, 5 = -1, 6 = -2, 7 = -3. For scoring, two linear terms are constructed 
to assess deviation from equity and over/underbenefit (Kuijer, Buunk, & Ybema, 2001). 
In the current study, the linear term for over/underbenefit was not examined as I was 
more interested in the deviation from equity rather than the direction of inequity. For the 
linear term of deviation from equity, the original scores representing underbenefit, -3, -2, 
and -1 are recoded to +3, +2, and +1, while the positive scores representing equity (0) and 
overbenefit remain the same, thus creating a four-point scale ranging from 0 (equity) to 3 
(inequity). For the purposes of this study, the linear term of deviation from equity will be 
designated as the predictor, and in some cases, the outcome variable. 
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No validity data had been reported for the modified equity measure (Kuijer, 
Buunk, & Ybema, 2001). The original similarly-worded Hatfield Global Equity measure 
(1978) correlates with other measures of equity, however.  Sprecher (1986,1988), for 
example, found the Hatfield Global measure is  positively and significantly correlated 
with the Sprecher Global Equity measure  (correlations range from r =.45, to .52, 
p<.001), which was created to measure day-today equity. Sprecher (2001) also ran 
correlations with a multi-faceted measure of equity to the Hatfield Global Measure (with 
r’s ranging from .43 to .73).  
As this is a one item measure, no internal consistency reliability metric can be 
computed. However, test-retest reliability data for the current sample was calculated and 
is reported below. To address potential concerns with reliability of the measure, I 
randomly selected one member of the dyad approximately one week after the study 
appointment to administer this item verbatim as the follow-up question described above. 
Responses from the member of the dyad were compared with the original response to 
calculate test-test reliability for this item. Results of the test-retest reliability analysis 
(N=21) indicate good reliability, Pearson’s r=.48, p=0.03.  
For the purposes of my analyses, support equity (from the initial questionnaire 
data) was treated as a predictor variable to test hypotheses 1-9 and as an 
outcome/dependent variable to test hypothesis 10.  
Depression. The severity of depression (i.e., higher total depression scores) was 
assessed using the Beck Depression Inventory – Fast Screen (BDI-FS; Beck, Steer, & 
Brown, 2000). The BDI-FS is a seven-item self-report inventory designed for the 
assessment of depression with medical populations, in which somatic symptoms due to 
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the patient’s medical condition may overlap with somatic criteria for depression. Thus, to 
minimize potential false positive cases of depression in these samples, the BDI-FS 
assesses the cognitive and affective factors of depression which has been recommended 
in HIV-positive samples (Kalichman, Rompa, & Cage, 2000; Kalichman, Sikkema, & 
Somlai, 1995). Participants marked their response for each item (a symptom of 
depression according to Diagnostic and Statistical Manual of Mental Disorders – Text 
Revision criteria [DSM-IV-TR]; American Psychological Association, 2000) that best 
describes how they were feeling in the past two weeks. Each item is rated on a 4-point 
scale, from 0 to 3, corresponding to an increase in severity for the depressive symptom. 
Previous research has reported adequate reliability for the BDI-FS, with good internal 
consistency (α = .831 in the current study). The BDI-FS has been used in HIV-positive 
populations with good validity and reliability. Krefetz and colleagues (2004) examined 
the psychometrics of the BDI-FS among a sample of HIV-positive patients with chronic 
pain, and found adequate internal consistency (α =.84) using a cut-off of scores greater 
4, correctly classified 81% of patients with a depressive disorder, and with 74% 
specificity and 90% sensitivity.  For this study, good internal consistency for the measure 
was observed, α =.83. For the purposes of my analyses, severity of depression (total 
depression score) was treated as an outcome variable to test hypotheses 4-6 and 10. 
Anxiety. The severity of anxiety (i.e., higher total anxiety scores) was assessed 
using the Beck Anxiety Inventory – Fast Screen (BAI-FS; Beck & Steer, 1993). The 
BAI-FS is a 7-item self-report inventory designed for the assessment of anxiety with 
medical populations, in which somatic symptoms due to the patient’s medical condition 
may overlap with somatic criteria for anxiety disorders. Thus, as with the BDI-FS, to 
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minimize potential false positive cases of anxiety disorders in these samples, the BAI-FS 
assesses the cognitive and affective factors of anxiety which has been recommended in 
HIV-positive samples. Respondents marked their response for each item (a symptom of 
anxiety according to the DSM-IV-TR; APA, 2000) that they may or may not have 
experienced over the past two weeks. Each item is rated on a 4-point scale, from 0 to 3, 
corresponding to an increase in the severity of the anxiety symptom. For this measure the 
items are simply summed. Beck et al. (1997) found that the sensitivity and specificity 
rates for identifying patients with and without anxiety disorders were, 85% and 81%, 
respectively, when a BAI-FS total cut-off score of 5 and above was used with 56 patients 
seeking medical treatment from family practice medical doctors. The coefficient α of the 
BAI-FS total scores with these patients was .90. The BAI-FS has been used in HIV-
positive populations with good validity and reliability results. Krefetz and colleagues 
(2004) examined the psychometrics of the BAI-FS among a sample of HIV-positive 
patients with chronic pain, and found adequate internal consistency (α =.80). For this 
study, adequate internal consistency for the measure was observed, α =.91. For the 
purposes of my analyses, anxiety severity (total anxiety score) was treated as an outcome 
variable to test hypotheses 7-10. 
Medication Adherence. To assess HIV medication adherence, a number of 
individual items were used, as recommended in the HIV medication adherence literature. 
For instance, Lu et al. (2008) compared multiple methods of self-reported HIV 
medication adherence with electronic measurement of medication adherence (the “gold 
standard” used in many randomized controlled clinical trials to monitor adherence) and 
found that a 1-month recall period was associated with less over-reporting of adherence 
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and that having patients rate their adherence over the past month was more accurate 
compared to having patients rate frequencies or percent of medication taken. Differing in 
some respects are Simoni and colleagues (2006) who recommend that investigators ask 
participants to self-report their medication adherence in several different ways such as 
using a 7-day recall, using normalizing language, and frame the question in different 
ways, such as using percentages and scale methods. To incorporate both sets of 
recommendations, several questions for self-reported questions were included such as (1) 
past 7-day recall of doses taken or missed, (2) percentage of medication taken in the last 
month using a visual analogue scale (0-100% with tick marks at intervals of 10), and (3) 
rating ability to take medications over the past month (Likert type scale; 1 very poor- 6 
excellent). To score item (1), the 7-day adherence was calculated as 1 minus the 
proportion of the sum of the missed doses for the 7 days divided by the total possible 
number of doses. Item (2) was scored by noting the position of the electronic slider bar 
corresponding with their self-rated percent adherence over the past month. Item (3) was a 
single value corresponding to the response chosen by the participant on the Likert-type 
scale.  For the purposes of my analyses, the three medication adherence items were 
included in correlational analyses and Item 2, or self-reported medication taken in the 
past month, was treated as the medication adherence outcome variable to test hypotheses 
1-3.  
Data Management and Preparation 
 After the participants comprising 34 dyads completed the ACASI electronic 
survey, data were downloaded from the QDS ACASI server, uploaded into the QDS Data 
Warehouse, and imported to SPSS for data management and descriptive analyses. Data 
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were then cleaned and screened for missing values and adjusted based on 
recommendations for handling missing data (Acock, 2005). Items were summed and 
scales were computed for all measures as detailed above.  
Data Analytic Strategy 
Descriptive statistics were calculated to describe the sample, independent sample 
T-tests were conducted to compare index participants and informal supporters with 
respect to sociodemographic and illness characteristics, and Pearson’s bivariate product-
moment correlations were run to examine associations between variables and to 
determine test-retest reliability for the Equity measure. To test hypotheses 1-10, 
inferential dyadic analytic methods described by Kenny, Kashy, & Cook (2006) were 
used which account for the probable non-independence of the dyadic data.  
Dyadic Data Analysis. Data from patients and their partners or other supporters 
cannot be assumed to be independent from each other as responses from partners are 
often correlated (Kenny et al., 2006). In any close relationship, dyads are likely to share 
similar traits or characteristics and characteristics of one member of the dyad may 
influence the other member of the dyad. Methods must take into account the non-
independence of dyadic data and should not be based on assumptions of independence of 
scores such as traditional multiple regression and analysis of variance approaches (Kenny 
et al., 2006).  
With dyadic analysis, appropriate data analytic techniques are chosen based in 
part of whether the two dyad members can be theoretically or empirically distinguished 
or ordered by a variable or factor, such as gender, family role, birth order, or disease 
status (Kenny et al., 2006).  However, since the participating dyads are a mix of 
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distinguishable (e.g., by gender, in the case of a dyad consisting of an HIV-positive male 
participant and an HIV-positive female) and indistinguishable (e.g., both male, HIV-
positive) subtypes and there is no way to order the members within the dyad, all were 
treated as indistinguishable in the analyses (Kenny & Ledermann, 2010).  
The Actor-Partner Interdependence Model (APIM) was used as a statistical 
framework for examination of the effect that the index participants’ predictor variable 
had on their own outcome variable (actor effect) and on the outcome variable of the dyad 
partners (partner effect) and vice-versa, while accounting for nonindependence in the 
dyad responses (see Figure 1). In this framework, the dyad is the level of analysis and 
each member of the dyad has a score on a particular independent or predictor variable, as 
well as a score on a particular outcome or dependent variable.  
 
 
 
 
 
 
 
 
Figure 1. The Actor-Partner Interdependence Model (APIM). “a” represents the actor effect, “p” represents the partner 
effect, “X1” and “X2” are the predictor variables for each member of the dyad, and “Y1” and “Y2” are the dependent 
(outcome) variables for each member of the dyad. “E1” and “E2” represent the unexplained sources of error influencing 
the outcomes. Note, the assignment of 1 and 2 are arbitrary due to the indistinguishable nature of the dyads. 
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The APIM analytic approach allows for simultaneous examination of the effects 
of the index participants’ and informal supporters’ predictor variables on their pooled 
values for the outcome variables (Kenny et al., 2006). For example, when using this 
method, it is possible to examine the effects of the respondent’s scores on equity or 
perceived social support on their own and on their partner’s outcome variables, such as 
depressive symptoms, anxiety symptoms, and medication adherence (partner effect). Due 
to the dyad members being indistinguishable in these data, there is only one actor effect 
and one partner effect for each predictor variable that contributes to the outcome variable. 
If the dyads were distinguishable (e.g., patients and healthy partners; heterosexual 
couples only), it would be possible to parse apart an actor effect and partner effect for 
each individual. Since the dyads are indistinguishable in this case, it would be arbitrary to 
categorically differentiate the two members of the dyad; instead the estimates must be 
pooled together (Kashy, Donnellan, Burt, and McGue, 2008).  
The APIM analytic approach allows for the testing of three different types of 
variables; namely, within-dyad variables, between-dyad variables, and mixed variables 
(Kenny et al., 2006). Scores on within-dyad variables are the same across dyads but vary 
between dyad members (e.g., gender among heterosexual couples as a categorical within-
dyads variable), whereas between-dyad variable scores are the same for members of the 
same dyad but vary across dyads (e.g., length of romantic relationship); and scores on 
mixed variables can vary both within and between dyads in the same study (e.g., both 
partners’ reports on their individual depressive symptoms; Kenny et al., 2006). In my 
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study, I am examining mixed variables (which are the only types of variables that can be 
used in analyses to examine the unique contributions of actor and partner effects) and a 
between-dyads variable, AIDS status concordance.  
The present study utilizes the APIM to examine the dyadic associations between 
equity and perceived social support with mental health (e.g., severity of anxiety and 
depressive symptoms) and medication adherence (see Figure 2), as well as dyadic 
associations between participant AIDS status concordance with equity, anxiety and 
depressive symptoms, and medication adherence (see Figure 3).  
 
 
 
 
 
 
 
 
 
Figure 2. The Actor-Partner Interdependence Model (APIM) as applied to the present study, representative of 
hypotheses 1-3. “a” represents the actor effect, “p” represents the partner effect, “Support Equity” and “Perceived 
Social Support” are the explanatory/predictor variables for each member of the dyad, and “Depression, ” “Anxiety,” 
and “Medication Adherence” are the dependent variables for each member of the dyad. “E1” and “E2” represent the 
unexplained sources of error influencing the outcomes. Note, the assignment of 1 and 2 are arbitrary due to the 
indistinguishable nature of the dyads.  
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Figure 3. The Actor-Partner Interdependence Model (APIM) as applied to the present study, representative of 
hypothesis 4. “a” represents the actor effect, “p” represents the partner effect, “AIDS status” is the 
explanatory/predictor variable for each member of the dyad, and “Support Equity,” “Depression,” and “Anxiety,” are 
the dependent variables for each member of the dyad. “E1” and “E2” represent the unexplained sources of error 
influencing the outcomes. Note, the assignment of 1 and 2 are arbitrary due to the indistinguishable nature of the dyads. 
 
Multilevel modeling (MLM; also known as hierarchical linear modeling or HLM) 
was used to estimate and test the APIM models. MLM has been recommended for 
analyses of non-independent indistinguishable dyadic data and this method allows for 
model coefficients to be estimated even when data are missing. Furthermore, MLM can 
also accommodate several types of dependent outcome variables and can be used to 
examine relationships between variables within a hierarchical data structure (Pollack, 
1998).  
For this study, dyads are considered to represent naturally occurring social groups 
of two people each. Within these parameters, there are two levels of data, upper Level 2 
(dyad) and lower Level 1 (index participant and informal supporters nested within a 
dyad). The two levels are associated with unique modeling of variances; namely, on 
Level 1, the variance and relationship between both members of the dyad on an outcome 
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variable is modeled and the dyad members’ responses are regressed on a predictor 
variable, while on Level 2, the variance in dyad means and dyad-level effects are 
modeled (Raudenbush, Brennan, & Barnett, 1995). MLM provides for the estimation of 
all model parameters (fixed and random sources of variance) within a single equation 
(Cook & Kenny, 2005). 
The parameters of the regression model, the intercept (or constant) and slope of 
the regression line (or regression coefficient) represent unique characteristics of the 
dyadic data. The intercept represents the predicted value of the outcome variable when 
the predictor variable score is set to zero (i.e., held constant). Thus, the intercept 
represents the grand dyadic mean on the outcome variable. The regression coefficient, or 
slope of the regression line, represents the fixed effect; more specifically, the difference 
in the outcome variable corresponding for every 1-unit difference in the predictor 
variables. The values of the intercept are allowed to vary across dyads, but the slopes are 
held equal (or constrained) across dyads (Kenny, Kashy, & Cook, 2006, p. 89). There are 
also random effects (or residuals) for the variation in intercepts and error variance. Below 
is an example of the Level-1 and Level-2 models to test the APIM with the 
indistinguishable dyads in the current study: 
Level 1: Yij(MEDADH) = β0j +  β1ij (ACT_SSSPSTOT) + β2ij (PART_SSSPSTOT) +  
β3ij(ACT_EQDEV) + β4ij (PART_EQDEV) 
 + rij 
Level 2: β0j = γ00 + V0j 
In the Level 1 model above, the notation β0 refers to the nonzero intercept or 
constant, while β1, β3, β5, and β7 represent actor parameter coefficients and β2, β4, and β6 
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represent partner parameter regression coefficients. The notation i represents the dyad, j 
is the individual within the dyad, r is a residual error term, and Y is the outcome variable, 
which in this instance is medication adherence. For the Level 2 model, V0j represents a 
random dyad effect.  
As applied to test the APIM models, multilevel modeling techniques are used to 
model scores on dependent variables as a function of the index participant’s and informal 
supporter’s scores on predictor variables. Consider the modeling of the index participant 
and informal supporter’s depressive symptoms as a function of their equity scores. Using 
the APIM model within the MLM analytic context, the index participant’s outcome score 
(e.g., depressive symptoms) is regressed onto the index participant’s own predictor 
variable score (e.g., equity). Regression coefficients from this aspect of the analysis; 
namely, the regression of index participant’s outcome scores (e.g., depressive symptoms) 
onto their own predictor variable (e.g., equity) scores represent the mean actor effect for 
the predictor variable (e.g., support equity). Concurrently, informal supporters’ outcome 
scores (e.g., depressive symptoms) are regressed onto informal supporters predictor 
scores (e.g., equity). Regression coefficients from this aspect of the analysis represent 
mean partner effects for equity scores. To put another way, actor effects are the influence 
of respondents’ ratings on their own outcomes and partner effects are the effects of the 
respondents’ ratings on the on the other dyad members’ outcomes. These are main 
effects.  
Data Structure 
 The data set for the study analyses was created in SPSS and imported into HLM7 
(Raudenbush, Bryk, & Congdon, 2004). The data were structured pairwise, as suggested 
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by Cook and Kenny (2005), with each individual participant having their own scores 
(actor) and their dyad partner scores (partner) recorded for each variable in the study. In 
the data set, each participant had their data recorded in one row, such that there were two 
rows for each dyad in the dataset. Each row included dyad ID, the participant’s outcome 
scores, and actor and partner values for the mixed predictor variables. Thus, each 
participant’s predictor values are entered twice, one as an actor variable for their own 
record, and once as a partner variable for the other dyad member’s record. As a special 
case, the categorical variable of participants’ AIDS status was dummy coded, designating 
values of 0 (no member of the dyad has a current diagnosis of AIDS), 1 (one member of 
the dyad has a current diagnosis of AIDS), and 2 (both members of the dyad have a 
current diagnosis of AIDS). A between-dyads variable, dyadic AIDS status concordance, 
was also created, following similar procedures as Eaton et al., 2009. This categorical 
variable was also effect coded, such that dyads with a concordant AIDS status would be 
represented with a code of 1 and dyads with a discordant AIDS status would be 
represented with a code of -1.  The “dyad ID” variable was the linking variable that 
signified which individuals were grouped within which dyads (Campbell & Kashy, 
2002).  
Data Analytic Procedures 
The first step in analyzing dyadic data, before testing hypotheses, is to assess 
nonindependence of the dyadic data (Kenny et al., 2006). Nonindependence of the 
indistinguishable dyadic data was tested by calculating the intraclass correlations for all 
of the variables for both the dyad members’ responses. According to Cohen (1988), 
intraclass correlations indicating non-independence can range from a small correlation of 
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0.1 to a large correlation of 0.5. Nonindependence of the data would also confirm that 
MLM is appropriate to estimate the APIM.  
For the MLM analyses, all of the predictor and outcome variables were treated as 
Level 1 (first level) mixed variables and the dyad identification variable served as the 
Level 2 (second level) variable to link the two nested levels of data. As such, the first-
level predictor variables represented the first-level fixed effects in analyses and the dyad 
ID variable represented the second-level random effect to account for possible 
correlations in relationship variables across individuals in the same dyad. In the 
multilevel modeling process, the first step is to fit a baseline (unconditional) model which 
provides estimates of the fixed and random parameters and variance of the intercept 
(dyadic mean) and slope (discrepancy score). If there was significant variation in the 
slope (discrepancy score) and intercept (dyadic mean), the next step would be to create a 
Level 2 model in which the slope and intercept are designated as outcome variables (Bryk 
& Raudenbush,1987). Unrestricted maximum likelihood (or full maximum likelihood) 
was the method of estimation used in HLM7 to produce estimates of variance and 
covariance parameters for each level of the unconditional models, while restricted 
maximum likelihood estimation was used to produce estimates of variance and 
covariance for the intercept. For all models, residuals for Level-1 variables (as a proxy 
for random effects) were assessed for normality within the HLM7 program. Additionally, 
each independent variable was grand-mean centered (i.e., subtracting the actual values 
from the mean) to minimize multicollinearity of predictors and to allow for 
straightforward interpretation of main effects in the regression models. Standard errors, 
degrees of freedom, t values, significance testing, alpha levels, and lower and upper 95% 
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confidence limits were also provided for each of the parameter estimates in the final 
models.   
To test hypothesis 1-3, multilevel modeling using HLM7 was conducted to 
examine the actor and partner main effects and interactions of the mixed predictor 
variables of equity (deviation from equity) and perceived social support (general and 
within the dyad relationship) on the mixed outcome variable of self-reported percentage 
of medication taken in the last month. Three separate models were created and tested. 
The first model I tested was the null model (baseline), which included only the outcome 
variable of past month medication adherence and no predictors; the effect of the intercept 
was estimated. The second model I tested included only actor values of perceived social 
support and partner values of perceived social support as predictors for past month 
adherence. I then tested a third model that included actor and partner values for equity (as 
measured by the deviation from equity term) because I hypothesized that equity would 
predict medication adherence above and beyond perceived social support. To examine 
whether the addition of variables at each step resulted in a statistically significant 
improved model fit, I conducted likelihood ratio tests, by computing and comparing the 
differences between the -2 Log Likelihood values for the different models (Campbell & 
Kashy, 2002).  
To test hypotheses 4-6, multilevel modeling using HLM7 was conducted to 
examine the actor and partner main effects of the mixed predictor variables of equity 
(deviation from equity) and perceived source-specific social support (within the dyad 
relationship) on the mixed outcome variable of total severity of depressive symptoms. 
Three separate models were created and tested. The first model I tested was the null 
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model (baseline), which included only the outcome variable of total severity of 
depressive symptoms and no predictors; the effect of the intercept was estimated. The 
second model I tested included only actor values for perceived source-specific social 
support and partner values for perceived social support (within the dyad relationship) as 
predictors for total severity of depressive symptoms. For these models, I examined the 
contribution of both actor effects and partner effects for the participants’ pooled scores on 
the outcome variable of severity of depressive symptoms 
I then tested a third model that included actor and partner values for equity (as 
measured by the deviation from equity term) because I hypothesized that equity would 
predict total severity of depressive symptoms above and beyond perceived social support. 
To examine whether the addition of variables at each step resulted in a statistically 
significant improved model fit, I conducted likelihood ratio tests by computing and 
comparing the differences in -2 Log Likelihood values for the different models 
(Campbell & Kashy, 2002).  
To test hypotheses 7-9, multilevel modeling using HLM7 was conducted to 
examine the actor and partner main effects of the mixed predictor variables of equity 
(deviation from equity) and source-specific perceived social support (within the dyad 
relationship) on the mixed outcome variable of total severity of anxiety symptoms. Three 
separate models were created and tested. The first model I tested was the null model 
(baseline), which included only the outcome variable of total anxiety severity and no 
predictors; the effect of the intercept was estimated. The second model I tested included 
only actor values for perceived social support and partner values for perceived social 
support as predictors for total severity of anxiety symptoms. I then tested a third model 
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that included actor and partner values for equity (as measured by the deviation from 
equity term) because I hypothesized that equity would predict total severity of anxiety 
symptoms above and beyond perceived social support. To examine whether the addition 
of variables at each step resulted in a statistically significant improved model fit, I 
conducted likelihood ratio tests, by computing and comparing the differences in -2 Log 
Likelihood values for the different models (Campbell & Kashy, 2002).  
To address hypothesis 10, multilevel modeling using HLM7 was conducted to 
examine whether the relationship between between-dyads predictor variable of AIDS 
status concordance and outcome variables of support equity, severity of depressive 
symptoms, and severity of anxiety symptoms differed depending on the influence of the 
concordance in dyad AIDS status. Three separate models were created, one for each 
combination of predictor (between-dyads variable of AIDS status concordance) and 
outcomes (medication adherence, severity of depressive symptoms, severity of anxiety 
symptoms). To test hypothesis 10, MLM was conducted to test the main effects of the 
dyad members’ AIDS status concordance on the mixed outcome variables of support 
equity, depressive symptoms, and anxiety symptoms. If there were potential confounding 
variables in the models that were significantly correlated with outcome variables, they 
were controlled for in all analyses.  
Results 
 Due to the limited sample size, significant and marginally significant differences 
and effects will be reported, so as to not exclude results that might achieve significance 
were these relationships tested within a larger sample size. 
Demographics and Descriptives 
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Sample Characteristics and Descriptives. During the recruitment phase of the 
larger mixed methods study from which these data were extracted, 161 individuals (index 
patients and informal supporters) called our lab to be screened for study participation; 88 
met the eligibility criteria to participate; and 68 individuals (34 dyads) completed the 
study. Reasons for ineligibility included participating in a similar previous study, not 
identifying as African American or Black (index patient only), not currently taking HIV 
medication (index patient only), not having an HIV-positive supporter (index patient 
only), reported history of violence within the dyad, being too busy to participate, refusing 
to be video recorded, being in bad health, and being out of contact with study staff (e.g., 
having disconnected phone numbers). The final sample included 68 participants 
comprising 34 dyads. The majority of the 68 participants were male (48, 70.6%), 
although 20 women participated, as well (20, 29.4%). Participants varied in age, from age 
22-66 (M=44.0; SD=22). For this HIV-positive sample, 18 participants (26.5%) had a 
current comorbid AIDS diagnosis, while the remaining 50 participants (73.5%) were 
HIV-positive and did not have a current AIDS diagnosis. Most participants lived at or 
below the poverty level, with 52 participants (76.5%) reporting an income of less than 
$1000 per month; 8 participants (11.8%) reported receiving $1000-1499 per month, 5 
participants (7.4%) reported receiving $1500-1999 per month, 2 participants (2.9%) 
reported receiving $2000-2499 per month, and 1 participant (1.5%) reported that their 
income was unknown. These descriptive data, along with measures of central tendency 
for predictor and outcome variables for models, are displayed in Table 1.  
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Table 1. Descriptive summary of sample 
Characteristics Mean (+/- S.D.) or n (%) 
Gender  
     Male 48 (70.6%%) 
     Female 20 (29.4%) 
Age (years) 44.0 (+/- 22.0) 
Income  
     Less than $1000/month 52 (76.5%) 
     $1000-1499/month 8 (11.8%) 
     $1500-1999/month 5 (7.4%) 
     $2000-2499/month 2 (2.9%) 
     Unknown 1 (1.5%) 
HIV status  
     HIV-positive, no current AIDS 
diagnosis 
50 (73.5%) 
     HIV-positive, current AIDS diagnosis 18 (26.5%) 
Years since HIV diagnosis known 14.37 (14.76) 
Source-Specific Social Support  35.39 (34.38), Range = 15-47 
Equity (Deviation from Equity)  1,12 (1.19), Range = 0-3 
Beck Depression Inventory-Fast Screen  4.74 (3.85), Range = 0-14 
Beck Anxiety Inventory-Fast Screen  7.40 (5.63), Range = 0-19 
Medication Adherence (N=58)  86.93% (20.29), Range = 0-100 
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Dyad-level attributes. For dyad-level attributes (Table 2), there were three types 
of dyads in terms of gender, with 19 male/male dyads (55.9%), 10 male/female dyads 
(29.4%), and 5 female/female dyads (14.7%). Dyad members reported being in various 
relationship types with each other including romantic relationships, with 8 dyads (23.53% 
of dyads) in romantic same-sex relationships, 3 dyads (8.83% of dyads) in romantic 
heterosexual relationships, while the majority of participants reported being in platonic 
relationships with each other with 21 dyads (61.8% of dyads) in friendships, while the 
remaining 2 dyads reported being family members (5.9% of dyads). Dyadic AIDS status 
was varied, with 18 dyads (52.9% of dyads) having both members concordant with an 
HIV positive diagnosis, but no AIDS diagnosis (i.e., HIV+/HV+), 2 dyads (5.9% of 
dyads) with a concordant AIDS diagnosis (i.e., AIDS/AIDS), and 14 dyads (41.2% of 
dyads) with a discordant AIDS status (i.e., HIV+/AIDS). 
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Table 2. Dyad-level attributes 
Characteristics Mean (+/- S.D.) or n (%) 
Gender  
     Male/male 19 (55.9%) 
     Male/female 10 (29.4%) 
     Female/female 5 (14.7%) 
Relationship types  
     Romantic relationships 11 (32.4%) 
          Same-sex relationships 8 (23.53%) 
          Heterosexual relationships 3 (8.83%) 
     Platonic relationships   
           Friendships 21 (61.8%) 
           Family members 2 (5.9%) 
Dyad AIDS status concordance  
     HIV+/HIV+ 18 (52.9%) 
     AIDS/AIDS 2 (5.9%) 
     HIV+/HIV+AIDS 14 (41.2%) 
 
Index patients and informal supporters were compared with respect to sociodemographic 
characteristics (see Table 3) and disease characteristics (see Table 4) using Chi-square or 
independent sample t-tests as appropriate. Independent sample t-tests were conducted to 
examine whether there were differences in sociodemographic characteristics, disease 
characteristics, perceived social support, support equity, depressive symptoms, anxiety 
symptoms, and medication adherence between index patients and informal supporters. 
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The results indicate a significant difference in the past month medication adherence for 
index patients and informal supporters who reported being prescribed medication (n=30); 
informal supporters rated significantly higher medication adherence (t=-2.18, p=.03) than 
index patients.  
Table 3. Comparisons between index patients and informal supporters on demographic 
and illness variables 
Characteristics Index patient 
Mean (S.D.) or 
n (%) 
Informal 
Supporters Mean 
(S.D.) or n (%) 
t or x
2
 p 
Age (years) 43.21 (9.21) 45.24 (10.51) -.85 .40 
Years Since HIV Dx 16.20 (19.36) 12.53 (7.77)   
Past month 
medication 
adherence (out of 
100) 
82.55 (24.73) 93.20 (10.45) -2.19 .03 
Undetectable viral 
load  
Yes: 16 
No: 11 
Yes: 18 
No:  5 
2.06 .15 
 
Table 4. Comparisons between index patients and informal supporters on predictor and 
outcome variables 
Characteristics Index patient 
Mean (S.D.) or n 
(%) 
Informal 
Supporters Mean 
(S.D.) or n (%) 
t or x
2
 p 
Source-specific social support, 
SSSPS 
35.32 (6.28) 35.42 (5.39) -0.07 .94 
Depression, BDI-FS 5.29 (4.76) 4.29 (3.59) .98 .08 
Anxiety, BDI-FS 7.70 (5.85) 6.26 (5.57) 1.04 .71 
Equity (raw score day of appt) 3.72 (1.92) 4.53 (1.38) -1.91 .06 
Deviation from equity  1.30 (1.34) 1.05 (1.08) 0.83 .41 
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Correlational Analyses (test-retest reliability). Pearson correlations were run to 
examine the scores on the equity measure (see Table 5) at the time of the study 
appointment and at a follow-up date approximately 1-2 weeks after the study 
appointment. Results of the zero-order correlations between the two sets of raw equity 
scores indicate that the two scores were correlated, r=0.48, p<.05.   
Table 5. Correlations among predictor and outcome variables in index patient-informal 
supporter dyads 
 1 2 
1 Raw equity scores at appointment  ------ ------ 
2 Raw equity scores at one-week followup .48* ----- 
*p<.05; **p<.001 
Inferential Analyses/Actor-Partner Interaction Model Analyses 
 Nonindependence and hierarchical linear modeling assumption testing. Tests 
to determine nonindependence for the indistinguishable dyads were conducted by 
computing intraclass correlations between scores on predictor and outcome variables 
reported by index participants and informal supporters. Results indicated that actor and 
partner predictor and outcome variables were not significantly correlated ( r=0.01, 
p=.37). However, when considering the sample size required for consequential 
nonindependence (at least 35 dyads), Kenny, Kashy, and Bolger (1998) recommend that 
the data be treated as nonindependent regardless and dyadic data analysis remains the 
appropriate method to use. Tests to examine assumptions of normality, equal variance, 
and linearity indicated that the assumptions were met for hierarchical logistic and linear 
regression.  
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 Actor-Partner Interdependence Model analyses. Results for the actor-partner 
interdependence model testing for each of the main hypotheses are presented next.  
 Perceived Social Support, Support Equity and Medication Adherence. For my 
first research question, I examined the degree to which equity compared with source-
specific perceived social support (within the dyad relationship) to predict medication 
adherence among participants (N=29 dyads currently on antiretroviral medications). I 
used HLM7 to conduct multilevel modeling of the interdependent data for index patient 
outcomes. Three hypotheses (1-3) and two models were tested; the first model included 
actor and partner values of source-specific perceived social support (i.e., Source-Specific 
Social Provisions Scale Total Score) as a predictor for past month medication adherence; 
the second model included actor and partner values for deviation from equity as an 
additional predictor for index patient past month medication adherence. 
 The distribution of the medication adherence variable was significantly skewed in 
the negative direction, with more participants reporting higher values of medication 
adherence in the past month. To address this non-normal distribution, data were 
transformed using a log transformation to meet the assumptions of normality inherent in 
multilevel modeling. The values that follow are in units of log transformed data.  
Results from the testing of the null models, presented in Table 6 indicated a 
significant Level 2 dyad effect on the dependent variable of past month medication 
adherence (p=<.01). Results from the test of variance components, presented in Table 7, 
indicate that there is a trend toward significance for the intercept of the outcome variable 
of past month medication adherence being affected by the Level 2 grouping variable of 
dyad (variance component =0.01, p=0.07). Furthermore, the variance component for the 
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intercept is less than the variance component of the level 1 residual variance component, 
indicating that additional variables in the model are needed to predict the remaining 
residual variance in the outcome variable of past month medication adherence for both 
the index patient and the informal supporter.   
Table 6. Null Model 1 Fixed Effects Results: Predicting Past Month Medication 
Adherence 
  
Model 1 (Null) 
Estimate (β) Standard 
Error 
t-ratio p 
Intercept 1.90 0.04 45.80 <.01 
 
Table 7. Final Estimation of Variance Components from Null Model 1: Predicting Past 
Month Medication Adherence  
  
Random 
Effect 
Standard 
Deviation 
Variance 
Component 
x
2
 p 
Intercept 0.12 0.01 39.73 0.07 
Level-1, r 0.27 0.07   
 
I hypothesized that greater levels of actor perceived social support (from the dyad 
partner) and greater actor equity (lower deviation from equity) would be associated with 
greater rates of medication adherence in the past month. The estimated coefficient for the 
level-1 predictors of actor perceived source-specific social support (i.e., respondents’ 
perceived support from the other dyad partner), partner perceived source-specific social 
support (i.e., the effect of the other dyad members’ perceived support ratings on one’s 
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own scores of perceived support) were -0.01 (p=0.87), 0.01, (p=0.20), while estimated 
coefficients for the level-1 predictors of actor perceived equity (i.e., respondents’ rating 
of equity in the dyad relationship), and partner perceived equity (i.e., the effect of the 
other dyad members’ equity rating on one’s own equity rating) were -0.01 (p=0.83), and 
0.05 (p=0.16), respectively. The results indicate that neither actor nor partner values of 
perceived source-specific social support nor ratings of equity had a significant effect on 
the dependent variable of past month medication adherence, according to patient self-
report. Thus, hypothesis one and two were not supported. 
To test hypothesis three, that equity of support (deviation from equity) will 
predict 30 day medication adherence above and beyond perceived social support, the 
goodness of fit of the full model including actor and partner values of Source-Specific 
Social Support and Equity predictors was compared to a model only including the actor 
and partner values of Source-Specific Social Support (see Tables 8 and 9 for model 
parameter estimates). Tests of the deviance statistic indicated that the contribution of the 
equity variables to the prediction of medication adherence was negligible (x
2
=2.16, 
p=.34).  
Table 8. Model 1 Fixed Effects:  The Actor-Partner Interdependence Model 
Demonstrating the Actor and Partner Relationships of Perceived Source-Specific Social 
Support and Equity to Predict Past Month Medication Adherence   
  
Model 1, Step 2 
Estimate (β) Standard 
Error 
t-value p 
Intercept 1.90 0.04 47.29 <.01 
Actor Perceived source-specific support -0.01 0.01 -0.29 0.77 
Partner Perceived source-specific support 0.01 0.01 1.29 0.21 
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Table 9. The Actor-Partner Interdependence Model demonstrating the actor and partner 
relationships of perceived social support and equity to medication adherence  
Model 1, Step 3  
 
Estimate 
(β) 
Standard 
Error 
t-value p 
Intercept 1.90 0.04 47.93 <0.01 
Actor Perceived source-specific support -0.01 0.01 -0.16 0.87 
Partner Perceived source-specific support 0.01 0.03 1.32 0.20 
Actor Equity (deviation from equity) -0.01 0.03 -0.22 0.83 
Partner Equity (deviation from equity) 0.05 0.03 1.46 0.16 
 
Perceived Social Support, Support Equity, and Depressive Symptoms. For my 
second research question, I examined the degree to which equity compared with source-
specific perceived social support (within the dyad relationship) to predict total severity of 
depressive symptoms among participants. I used HLM7 to conduct multilevel modeling 
of the data. Three hypotheses (4-6) and three models were tested; the first model which 
included the Level 2 grouping variable of dyad as well as the outcome variable of total 
depressive symptoms; the second model included the additional variables of actor and 
partner values of perceived social support (i.e., Source-Specific Social Provisions Scale 
Total Score) as a predictor for total severity of depressive symptoms; the third model 
included actor and partner values for equity (i.e., deviation from equity term) as an 
additional predictor variable for total severity of depressive symptoms.  
Results from the testing of the null models (see Table 10) indicated a significant 
Level 2 dyad effect on the dependent variable of total severity of depressive symptoms 
51 
 
 
 
(p=<.01). That is to say, there was a significant main effect for the intercept estimate. 
However, results from the test of variance components, presented in Table 11, indicate 
that the variance of the intercept of the outcome variable of total severity of depressive 
symptoms was not significantly related to the Level 2 grouping variable of dyad 
(variance component =0.40 , p=0.40).    
Table 10. Null model predicting depressive symptoms among participants - effects 
  
Model 2, Step 1 Estimate 
(β) 
Standard 
Error 
t p  
Intercept 4.79 0.52 9.28 <0.01 
 
Table 11. Null model predicting depressive symptoms among participants– final 
estimation of variance components 
  
Random Effect Standard 
Deviation 
Variance 
Component 
x
2
 p  
Intercept 0.63 0.40 34.53 0.40 
Level-1, r 4.17 17.35   
 
I hypothesized that greater levels of actor perceived social support (from the dyad 
partner) and greater actor equity (lower deviation from equity) would be associated with 
lower rates of total severity of depressive symptoms. The results of fixed effect testing 
(see Table 12 and 13) demonstrated a significant actor effect for perceived social support. 
When the other predictor variables in the model were held constant, for every one-point 
increase in actor source-specific perceived social support, there was a 0.27 point decrease 
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in total severity of depressive symptoms (p=0.01). However, equity as a predictor of total 
depressive symptoms was not significant in tests of fixed effects; thus, hypothesis four 
was only partially supported. As no partner effects were significant (indicating there was 
no effect of the other dyad members’ perceived support or equity ratings on one’s own 
rating of depressive symptoms), hypothesis five was not supported.    
Table 12. Actor-Partner Interdependence Model demonstrating the actor and partner 
relationships of source-specific perceived social support predicting depressive symptoms 
Model 2, Step 2 Estimate 
(β) 
Standard 
Error 
t p  
Intercept 4.79 0.47 10.25 <0.01 
Actor Perceived Source-Specific Social 
Support 
-0.25 0.09 -2.79 0.01 
Partner Perceived Source-Specific Social 
Support 
-0.06 0.09 -0.63 0.53 
 
Table 13. The Actor-Partner Interdependence Model demonstrating the actor and partner 
relationships of perceived social support and equity to depressive symptoms 
Model 2, Step 3 Estimate 
(β) 
Standard 
Error 
t p  
Intercept 4.79 0.46 10.45 <0.01 
Actor Perceived Source-Specific Social 
Support 
-0.27 0.09 -2.98 0.01 
Partner Perceived Source-Specific Social 
Support 
-0.04 0.09 -0.46 0.65 
Actor Equity (deviation from equity) 0.62 0.39 1.62 0.12 
Partner Equity (deviation from equity) 0.03 0.39 0.09 0.93 
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 To test hypothesis six, that equity of support (deviation from equity) will predict 
total severity of depressive symptoms above and beyond perceived social support, the 
goodness of fit of the full model including actor and partner values of Source-Specific 
Social Support and Equity predictors was compared to a model only including the actor 
and partner values of Source-Specific Social Support (see Table 13 for parameter values). 
Tests of the deviance statistic indicated that the contribution of the equity variables to the 
prediction of total severity of depressive symptoms was negligible (x
2
=22.72, p=0.27). 
Thus, hypothesis six was not supported and the contribution of the actor and partner 
values for equity (deviation) to the predictive model for total severity of depressive 
symptoms was negligible.   
Table 13. The Actor-Partner Interdependence Model demonstrating the actor and partner 
relationships of perceived social support and equity to depressive symptoms 
Model 2, Step 3 Estimate 
(β) 
Standard 
Error 
t p  
Intercept 4.79 0.46 10.45 <0.01 
Actor Perceived Source-Specific Social 
Support 
-0.27 0.09 -2.98 0.01 
Partner Perceived Source-Specific Social 
Support 
-0.04 0.09 -0.46 0.65 
Actor Equity (deviation from equity) 0.62 0.39 1.62 0.12 
Partner Equity (deviation from equity) 0.03 0.39 0.09 0.93 
 
Perceived Social Support, Support Equity, and Anxiety Symptoms. The third 
research question examined the degree to which equity compared with source-specific 
perceived social support (within the dyad relationship) to predict total severity of anxiety 
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symptoms among participants. I used HLM7 to conduct multilevel modeling of the 
interdependent data. Three hypotheses (7-9) and three models were tested; the first model 
which included the Level 2 grouping variable of dyad as well as the outcome variable of 
total severity of anxiety symptoms; the second model included the additional variables of 
actor and partner values of perceived social support (i.e., Source-Specific Social 
Provisions Scale Total Score) as predictive of total severity of anxiety symptoms; the 
third model included actor and partner values for equity (i.e., deviation from equity term) 
as predictive of total severity of anxiety symptoms.  
Results from the testing of the null models indicated a significant Level 2 dyad 
effect on the dependent variable of total severity of anxiety symptoms (p=<.01; Table 
14). Results from the test of variance components, presented in Table 15, indicate that the 
variance of the intercept of the outcome variable of total severity of anxiety symptoms 
was not significantly related to the Level 2 grouping variable of dyad (variance 
component =0.05 , p=>.5; Table 15).  
Table 14. Null model predicting anxiety symptoms among participants – final estimation 
of variance components 
  
Random Effect Standard 
Deviation 
Variance 
Component 
x
2
 p  
Intercept 0.22 0.05 29.16 >0.5 
Level-1, r 5.72 32.66   
 
I hypothesized that greater levels of actor perceived social support (from the dyad 
partner) and actors’ perception of greater equity (lower deviation from equity) would be 
associated with lower total severity of anxiety symptoms. The results of fixed effect 
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testing (see Table 15 and 16) demonstrated a trend toward significance for an actor effect 
for perceived social support as a predictive of total severity of anxiety symptoms. When 
the other predictor variables in the model were held constant, for every one-point increase 
in actor source-specific perceived social support, there was a 0.26 point decrease in total 
severity of anxiety symptoms (p=0.06). However, equity as a predictor of total anxiety 
symptoms was not significant in tests of fixed effects; thus, hypothesis seven was only 
partially supported. As no partner effects were significant (indicating there was no effect 
of the other dyad members’ perceived support or equity ratings on one’s own rating of 
anxiety symptoms), hypothesis eight was not supported.    
Table 15. Null model predicting anxiety symptoms among participants - effects 
   
Model 3, Step 1 Estimate 
(β) 
Standard 
Error 
t p  
Intercept 6.99 0.69 10.06 <0.01 
 
Table 16. Actor-Partner Interdependence Model demonstrating the actor and partner 
relationships of source-specific perceived social support predicting anxiety symptoms 
among participants 
   
Model 3, Step 2 Estimate 
(β) 
Standard 
Error 
t p  
Intercept 6.99 0.66 10.58 <0.01 
Actor Perceived source-specific support  -0.26 0.13 -2.06 0.05 
Partner Perceived source-specific support -0.03 0.13 -0.27 0.79 
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To test hypothesis nine, that equity of support (deviation from equity) will predict 
total severity of anxiety symptoms above and beyond perceived social support, the 
goodness of fit of the full model including actor and partner values of Source-Specific 
Social Support and Equity predictors was compared to a model only including the actor 
and partner values of Source-Specific Social Support (see Table 17 for model parameter 
values). Tests of the deviance statistic indicated that the contribution of the equity 
variables to the prediction of total severity of anxiety symptoms was not significant 
(x
2
=0.87, p=>.5). Thus, hypothesis nine was not supported. 
Table 17. The Actor-Partner Interdependence Model demonstrating the actor and partner 
relationships of source-specific perceived social support and equity to anxiety symptoms 
among participants 
   
Model 3. Step 3 Estimate 
(β) 
Standard 
Error 
t p 
Intercept 6.99 0.66 10.64 <0.01 
Actor Perceived source-specific support  -0.26 0.13 -1.99 0.06 
Partner Perceived source-specific support -0.03 0.13 -0.23 0.82 
Actor Equity (deviation from equity) 0.37 0.55 0.68 0.51 
Partner Equity (deviation from equity) 0.35 0.56 0.63 0.53 
 
 AIDS Status, and Support Equity, Depressive and Anxiety Symptoms. The 
fourth research question was focused on whether the relationship between AIDS status 
concordance and outcome variables of equity, severity of depressive symptoms, and 
severity of anxiety symptoms differed depending on the concordance of dyad AIDS 
status among participants. I used HLM7 to conduct multilevel modeling of the 
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interdependent data. One hypothesis (10) and three models were tested.  The between-
dyads variable of dyad concordance was created by assigning dummy codes to dyads for 
AIDS status concordance, with 0 signifying discordant dyads and 1 signifying concordant 
dyads. This variable was included as a level 2 variable in the regression models. Results 
of fixed effects (see Tables 18, 19, and 20) did not demonstrate significant effects for 
dyad AIDS status concordance on the outcome variables of equity, total severity of 
depressive symptoms, or total severity of anxiety symptoms, thus Hypothesis 10 was not 
supported. 
Table 18. The Actor-Partner Interdependence Model demonstrating AIDS status 
concordance as a between-dyads variable predictor of equity (deviation from equity) 
among participants 
 β Standard Error t p 
Intercept 1.26 0.25 5.06 <0.01 
AIDS status concordance -0.13 0.32 -0.42 0.68 
 
Table 19. The Actor-Partner Interdependence Model demonstrating AIDS status 
concordance as a between-dyads variable predictor of depression among participants 
 β Standard Error t p 
Intercept 4.54 0.82 5.56 <0.01 
AIDS status concordance 0.44 1.06 0.41 0.69 
 
Table 20. The Actor-Partner Interdependence Model demonstrating AIDS status 
concordance as a between-dyads variable predictor of anxiety among participants 
 β Standard Error t p 
Intercept 6.71 1.09 6.17 <0.01 
AIDS status concordance 0.46 1.42 0.32 0.75 
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Discussion 
 The aim of this study was to better understand whether HIV-positive individuals’ 
and their HIV-positive supporters’ perceptions of support availability and balance (i.e., 
equity) within their relationship are associated with their own and their supporters’ 
mental health and treatment-related health outcomes.  Using the Actor-Partner 
Interdependence Model as a conceptual framework and hierarchical linear modeling as 
the statistical approach, the relationships between perceived source-specific social 
support and equity with depressive symptoms, anxiety symptoms, and medication 
adherence for index patients and their self-identified informal supporters were examined.  
In this study, there was evidence of significant actor effects of perceived support 
from one’s dyadic partner (i.e., source-specific social support) on total depressive 
symptoms and total anxiety symptoms, as hypothesized. Specifically, greater perception 
of dyadic social support was associated with fewer depressive or anxiety symptoms. 
Although there is a dearth of research examining source-specific social support among 
dyads with chronic illness (and no research examining source-specific social support for 
dyads in supportive relationships coping with HIV), the closest proxy may be the 
perception of partner or spousal support from studies in which one member of the couple 
has a chronic illness, most commonly cancer. My findings are consistent with others’ 
research, such as Gremore and colleagues (2011) who found negative relationships 
between partner support and depressive symptoms among women coping with breast 
cancer and their healthy partners. In a similar vein, Lal & Bartle-Haring (2011) found that 
partner unsupportive behavior was positively associated with depression among patients 
with chronic lung disease. Findings from psycho-oncology literature suggest a negative 
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relationship between perceived family support and psychological distress among patients 
and healthy spouses coping with prostate and breast cancer (Baider, Ever-Hadani, 
Goldzweig, Wygoda, & Peretz, 2003). When researchers have examined general social 
support in the context of patients and their healthy partners coping with chronic illness, 
they have found such social support was negatively associated with psychological 
distress (Barry, Kasl, Lichtman, Vaccarino, & Krumholz, 2006; Thomson, Molloy, & 
Chung, 2012. 
Contrary to my expectations, participants’ perceptions of source- specific social 
support were not related to participants’ past month medication adherence. The 
relationship between social support and HIV medication adherence in the literature has 
been documented as largely positive (Andersen et al., 2000; DiMatteo, 2004; Persson, 
Ostgergren, Hanson, Lindgren, & Naucler, 2002), wherein greater perceptions of social 
support have been associated with greater rates of medication adherence. Conversely, 
there is literature indicating negative or neutral associations between perceived support 
and HIV medication adherence (Johnson et al., 2003; Knowlton et al., 2011). In the 
current study, it may be that the statistically insignificant results are due to neutral effects 
of the support perceived from their dyad partner, or due to low power to detect effects.  
The literature also shows us that not all support is created equal and there may be 
variability in the relationships between support and adherence based on the supporter and 
the perception of the nature of support for adherence. For instance, Wrubel, Stumbo, & 
Johnson (2010) have examined the dynamics of received support among serodiscordant 
and seroconcordant couples with HIV. The results of their qualitative interviews reveal 
variability in the attributions of who provides support for adherence; whether adherence 
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is viewed as a personal responsibility or couple responsibility depended on support 
preferences and the support exchange context of relationships. Thus, it may be that 
participants in our study tended to identify adherence as a personal responsibility and 
perceived support did not play a significant role with respect to their medication 
adherence. Moreover, relationship partners may be sought for particular types of support. 
For example, Stumbo, Wrubel, & Johnson, (2011) found that HIV-positive individuals 
sought instrumental or tangible support from their partners while receiving and seeing 
informal and emotional support from family members and friends. Although the sample 
size is too small to examine support and adherence patterns by relationship type, we 
might consider that index participants were not as reliant on supporters for adherence-
related support based on their relation with the supporter.  
 Contrary to what I hypothesized, there was no evidence of significant partner 
effects for any of the study hypotheses. Thus, the results from this study may be most 
consistent with an actor-oriented model (Kenny & Cook, 1999), wherein the participants’ 
outcomes are a function of the individuals’ perceptions themselves, and their partners’ 
perceptions have no effect on the individuals’ outcomes. These results may be due to the 
nature of the dyads, in which both individuals are simultaneous coping with their own 
illness. Thus, participants may be more individually focused on their own coping with 
illness and there may be less carryover in terms of how their perceptions of social support 
and equity influence their supporters’ mental health and treatment outcomes. Most of the 
literature examining mental health and treatment outcomes in a dyadic context 
incorporates patients and their healthy partners or caregivers, where there are distinct 
roles and supporters are often focused on the patient and their outcomes. In addition, a 
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larger sample size for the current study may have increased the likelihood of detecting 
partner effects.  
Surprisingly, participants’ own and dyad partners’ perceptions of equity (i.e., 
deviation from equity) were not identified as significant predictors for any of the outcome 
variables. Although there is no research examining associations between equity and 
medication adherence, there is literature that supports associations between perceptions 
of inequity and psychological distress (Kuijer et al., 2001; Ybema, Kuijer, Buunk, 
DeJong, & Sanderman, 2001; Ybema et al., 2002).  Perhaps an examination of reciprocity 
of support exchange (i.e., the balance between received and provided support 
transactions) rather than global perceptions of equity may better capture the negative 
effects of inequitable support (Kleiboer et al., 2006). On the other hand, researchers have 
argued that meeting partner needs in intimate relationships may be more important to 
individuals than having equity of support in the relationship (Clark & Mills, 1979; Clark 
& Chrisman, 1994).  Another possibility to consider is the concept of equity preferences; 
that is, individuals’ preferences for equity in their relationships. For instance, dyadic 
relationships may be set up in a way that one partner may be more comfortable giving 
support while the other partner may be more comfortable receiving support. Future work 
should incorporate an examination of equity preferences and equity agreements in 
relationships. Additionally, others have argued that perceptions of inequity may be more 
closely associated with relationship quality than with distress (Kuijer, Buunk, DeJong, 
Ybema, & Sanderman, 2004). To address this issue, future work should include measures 
of relationship quality into studies assessing the relationship between equity, 
psychological distress, and treatment outcomes.  
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Additionally, the non-significant results may be due to the way in which equity 
was measured as a global assessment and not a more discrete measurement. Investigators 
have also examined aspects of equity through use of author-derived scales assessing 
perceptions of underinvestment and perceptions of underbenefit (Ybema et al., 2001) and 
examining reciprocity of emotional and instrumental social support exchanges as a proxy 
for equity through diary or daily report studies (Gleason, Iida, Bolger, & Shrout, 2003; 
Kleiboer et al., 2006). Future studies should incorporate multiple measures of equity and 
reciprocity to gain a more comprehensive understanding of the nuances with respect to 
balance of support in relationships with respect to mental health and treatment outcomes. 
The assessment of equity should also occur at multiple time points. For example, the item 
in the current study is focused on perceptions of equity “at this moment” or the day of the 
appointment. A more stable assessment of equity might be obtained if participants were 
asked to consider the equity in their relationships over the past month, past year, and so 
forth. This may, in part, explain why the correlation between the equity ratings at the time 
of the appointment and one week later was not very strong. Additionally, the power 
issues may be associated with the lack of significance. With regard to future analyses of 
this data, it would be interesting to examine associations between the raw scores on the 
equity measure and outcome variables, as index patients and informal supporters differed 
on this score and the distribution would have more variability with the 7-point scale 
compared with the 4-point scale for deviation from equity.  
 Finally, there were no significant predictor effects of AIDS status concordance on 
the outcome variables of equity, depressive symptoms, or anxiety symptoms among 
dyads. Although there was a sizable proportion of dyads in our sample with a discordant 
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dyads AIDS status, perhaps their difference in AIDS status was did not play the most 
prominent role with respect to mental health and equity in the relationship. It may be the 
case that a more specific operationalization of discrepancy in health status or 
multifactorial assessment of health status was needed; this might be inclusion of 
symptom burden, health-related quality of life, functional limitations, or number of 
AIDS-defining conditions or complications as a way to assess the significance of 
participants’ health status. It may also be the case that when there is a discrepancy in 
health status and one partner in the dyad has pressing health needs, equity may not be as 
much of a concern and needs-based rules for the relationship may dominate (Clark & 
Mills, 1979; Kuijer et al., 2001). Alternatively, perhaps examining concordance in a 
construct such as supporter burden or supporter role overload might better capture the 
relationship to mental health and equity in the relationship. For instance, significant 
caregiver burden and role overload have been described among HIV-positive caregivers, 
and have been associated with deleterious mental health outcomes and compromised self-
care and management of HIV (Edwards, Irving, & Hawkins, 2011; Folkman et al., 1994; 
Land & Hudson, 2004; Land, Hudson, & Stiefel, 2003; Wight, 2000). Although burden 
and role overload associated with the provision of informal support was not examined 
explicitly in the present study, it may be an important area for future exploration with 
respect to equity and mental health in seropositive dyads. Furthermore, given the 
spectrum of relationship types representing in our sample (i.e., ranging from friendships 
to intimate relationships), the impact of a differential health status may not be as 
powerful on patients’ or supporters’ mental health and perceptions of equity in the 
relationship. The small sample size precludes further subdivision to examine the potential 
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differences in the relationships between AIDS status concordance, mental health, and 
equity by relationship type; however, future research is recommended to examine 
differences in these constructs.   
Limitations 
Although findings from my study contribute to an understanding of equity and 
social support within HIV-affected relationships, there were several significant 
limitations that may have influenced the results. One such limitation pertains to the 
sample size. The sample size was small and as a result, there was reduced power to detect 
large effects. Specifically, I was only able to detect small effects which required a large 
difference. Although dyadic data analysis using multilevel modeling has been conducted 
with small samples, it is often the case that these studies too may have been 
underpowered. With additional participants, I would expect to find stronger relationships 
between key variables of interest.  
There are a number of factors that may limit the generalizability of these results, 
including response biases common to self-report measures (e.g., erroneous recall and 
social desirability responding). Another issue affecting generalizability may be a self-
selection bias due to the way in which dyads were recruited and enrolled in the study. For 
instance, index patients did the recruiting of the informal supporters and it is possible that 
the index participants perceived a more close relationship with the supporter than vice 
versa. However, we did attempt to minimize this by doing extensive screening of both 
partners to try to ensure that they were in a mutually supportive relationship of 
significance and free of abuse.  Additionally, the participants in this study were quite 
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impoverished which may have influenced their perceived support (e.g., reduced financial 
support) and the relevance of perceived equity versus getting their needs met.  
 Additionally, the way in which the construct of equity was measured in this study 
may be a limitation. The use of a single item measure is not ideal. In future studies, 
inclusion of multiple methods of assessment of equity within the dyad will be 
implemented. Additionally, a construct that has been discussed as distinct from equity, 
but related, is reciprocity of support or the perception of returning support to others. 
Perhaps reciprocity may be relevant in this context of shared HIV illness and an 
interaction between equity and reciprocity on the outcome variables may have been 
observed.  Future inclusion of the assessment of reciprocity in this line of research is 
recommended.  
 Finally, we utilized a cross-sectional research design for this project. Thus, causal 
inferences between perceived source-specific social support, equity, depressive 
symptoms, anxiety symptoms, and medication adherence cannot be established. That is to 
say, social support could improve mental health outcomes, but positive mental health 
could also influence how supportive one sees those around him or her. Longitudinal 
research is recommended to examine how the relationships between these variables may 
change over the course of coping with HIV/AIDS. Despite these limitations, there is still 
important information to be gained from this research, which holds promise for future 
research investigations and clinical practice.  
Implications, Future Directions, and Conclusion 
Little is known about how the nuances and contextual factors associated with 
social support influence mental health and medication adherence outcomes in the context 
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of HIV. The present study was the first to examine, in a dyadic context, perceptions of 
equity among members of supportive relationships who are both HIV-positive. In fact, 
this study was the first to my knowledge to examine equity among dyads diagnosed with 
the same illness. Most investigators have examined coping and adjustment to chronic 
illnesses for patients and their healthy caregivers or healthy spouses. The results from this 
study indicate the protective effects of individuals’ perceptions of being supported by a 
specific support person, generalized among a variety of relationships, on depressive and 
anxiety symptoms.  
These results, although tentative, may imply that perceptions of support from 
important support persons of patients with HIV/AIDS are important with respect to 
mental health outcomes. Informal supporters who are also seropositive may be 
particularly useful supporters for people living with HIV/AIDS as they may be a source 
of peer support and education. Providers should work with patients when assessing their 
social support network, to identify potential supporters and in particular, supporters who 
may be HIV-positive.  
Additional research is needed to learn how patients assess and evaluate support 
and equity within the relationship (e.g., whether certain forms of support contribute more 
to perceptions of equity than others), whether optimal matching of support plays a role 
with respect to perceptions of equity, and the mechanisms by which equity influences 
mental health, adherence to medication, and treatment engagement more broadly. 
Longitudinal research is recommended to examine changes in perceived equity and its 
relationship with mental health and treatment outcomes over time. Qualitative research 
examining the nature of various types of supportive HIV-seropositive relationships is 
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recommended to gain a better picture of the nuances in perceptions of support and the 
rules that may govern these relationships, whether it be having the perception of an 
equitable relationship, one in which individuals have their needs met, or some other type 
of dynamic that may be operating. Considering that these participants were living at or 
below the poverty level, it may be the case that getting their needs met, and obtaining 
instrumental or tangible forms of social support, may be more relevant than perceiving 
that the give and take within the relationship is equal. These and many other research 
questions are waiting to be answered.  
Conclusions 
 The receipt and provision of informal support and informal caregiving in the 
context of HIV/AIDS is common, particularly among populations that are 
disproportionately affected by the illness, such as African Americans. Yet, there remains 
much to be explored about the exchange and perceptions of support within close 
relationships of those coping with HIV/AIDS while providing support to others. If we are 
to gain a better understanding of how to utilize social support outside of the medical 
context to positively affect medical outcomes, we must examine the nuances of social 
support within these close relationships to understand their impact on individuals’ and 
their supporters’ mental health and treatment outcomes. This research is one of many 
steps toward a better understanding of the support dynamics within broad HIV 
seroconcordant relationships. 
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Appendix B. HIV Communication Survey (Selected Items Used in Dissertation 
Research) 
 
PI: Katie E. Mosack, Ph.D.; Student Co-PI: Angela R. Wendorf 
 
Note: Survey is administered via QDS (ACASI) software and participants do not see 
question numbers or skip pattern directives, below. 
 
Thank you for agreeing to participate in our study. We appreciate your time and 
honesty; your responses will help us improve and understand HIV treatment 
planning for those diagnosed with HIV/AIDS and their loved ones.  Please be aware 
that some questions will be about your experiences with HIV. For others, we will ask 
you your thoughts about the experiences of the person who came with you today. If 
you have any questions as you complete this survey, please ask the interviewer.  
 
Demographics 
 
1. What year were you born?      
 
2. What month were you born?      
 
3. What is your age in years?      
 
4. What is your gender?  
 Male  
 Female  
 MTF Transgender  
 FTM Transgender  
 Other (please specify) ____    ________________ 
 
5. What most closely defines your current relationship status?  
 Not dating 
 Dating casually 
 In a committed relationship  
 Other (please specify) ___________________   
 _ 
 
6. With which race and/or ethnicity do you identify (select all that apply): 
 White/Caucasian  
 Black/African American 
 Hispanic/Latino /a 
 Asian or Pacific Islander  
 Native American  
 Other (please specify): _____________   
 _______ 
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7. What is the highest level of education you have completed? (select one) 
 Grade School  
 Some High School  
 Finished High School or High School Equivalent (GED) 
 Some College (no degree)  
 Earned Associates Degree 
 Earned Technical Degree  
 Earned a Bachelor’s Degree  
 Earned a Master's  Degree  
 Earned Doctorate/Medical/Law degree  
 
8. Considering all sources of income, how much do you take home each month 
(gross income)? 
 0 (I did not receive or make any money) 
 $1-499/month 
 $500-999/month 
 $1000-1499/month 
 $1500-1999/month 
 $2000-2499/month 
 $2500 or more/month 
 
9. Do you have any children?  
 Yes 
 No 
 
If “No”, skip Question 10 and 11, and continue to Question 12.  If “Yes”, 
continue to question 10 
 
10. How many do you have?     
 
11. How many children live with you?      
 
Now, we would like to ask you about ask you about your health, health care, 
medical appointments, your relationship with your doctor, and your experiences 
with medications. In all cases, we ask you to focus on your care and treatment as it 
relates to HIV. 
 
12. Have you ever been tested for and/or diagnosed with HIV?  
 Yes 
 No 
 
If “no” skip questions 13 – 42 and continue to question 43. If ‘yes” continue to 
question 13. 
  
13. What is your current HIV status (choose one) 
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 HIV-positive, currently diagnosed with AIDS   
 HIV-positive, no current AIDS diagnosis  
i. If you answered “HIV-positive, no current AIDS diagnosis,” have 
you ever been diagnosed with AIDS?  
 Yes 
 No 
 
14. Where were you diagnosed?  
 STD clinic 
 Planned Parenthood 
 Primary Care Physician’s Office 
 Community Health Center 
 Health Department 
 Hospital 
 Blood bank 
 Emergency Room/Urgent Care 
 While locked up (e.g., jail, prison, detention facility) 
 Other (please specify):        
 
15. In what year were you diagnosed with HIV?  
 19   
 20   
 I don’t remember the year* 
*If you don’t remember exactly what year you were diagnosed, please 
estimate the year you may have been diagnosed:     
 
16. In what month were you diagnosed with HIV?      
 
Medication Adherence 
 
17. Each time you take your medications we consider that to be a dose. How many 
doses of your HIV medications do you take each day?  
 1 dose  
 2 doses 
 3 doses 
 
If you answered 1 dose answer question 33, then continue to question 37. 
 
If you answered 2 doses answer question 34 and 35, then continue to question 37 
 
If you answered 3 doses answer question 34, 35, and 36 then continue to question 37 
 
18. Of the 7 doses you were supposed to take during the last week, how many did you 
miss?  
 1 
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 2 
 3 
 4 
 5 
 6 
 7 
 
19. Of the 7 morning doses you were supposed to take during the last week, how 
many did you miss?  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 
20. Of the 7 evening doses you were supposed to take during the last week, how 
many did you miss?  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 
21. Of the 7 afternoon doses you were supposed to take during the last week, how 
many did you miss?  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 
22. Many patients find it difficult to take all their HIV medication exactly as 
prescribed. Put a mark on the line below at the point that shows your best guess 
about how much of your prescribed HIV medication you have taken in the last 
month. We would be surprised if this were 100% for most people.  
 
Example: 0% means you have taken no medication 
50% means you have taken half your medication or all your medication about half the 
time 
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100% means you have taken every single dose of your medication 
 
          
 
 
23. During the past month, rate your ability to take all your medications as prescribed 
 Very poor 
 Poor 
 Fair 
 Good 
 Very Good 
 Excellent 
 
Anxiety Symptoms  
 
Assessed with the Beck Anxiety Inventory – Fast Screen/Primary Care)- Sample items 
are not reproduced.  
 
 
Depressive Symptoms  
Assessed with the Beck Depression Inventory – Fast Screen – Sample items are not 
reproduced. 
 
 
Source-Specific Perceived Social Support 
 
In answering the next set of questions, please think specifically about your current 
relationship with the person who came with you today. As a reminder, none of the 
information that you provide will be shared with this person. Thank you again for 
your honesty.  
 
24. Please indicate to what extent each statement describes your current relationship 
with the person that came with you today. Use the following scale to indicate your 
opinion: So, for example, if you feel a statement is very true of your relationship 
with the person that came with you today, you would respond with “strongly 
agree.” If you feel a statement clearly does not describe your relationship, you 
would respond with “strongly disagree.” 
 
 Strongly 
Disagree Disagree Agree 
Strongly 
Agree 
I can depend on him/her to help if I really need it.          
0 10 20 30 40 50 60 70 80 90 100 
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I feel that I could not turn to him/her for guidance in times 
of stress.  
        
S/he enjoys the same social activities that I do.          
I feel personally responsible for his/her well being.          
I feel s/he does not respect my skills and abilities.          
If something went wrong, I feel that s/he would not come 
to my assistance.  
        
My relationship with him/her provides me with a sense of 
emotional security and well-being.  
        
I feel my competence and skill are recognized by him/her.          
I feel s/he does not share my interests and concerns.          
I feel s/he does not really rely on me for their well-being.          
I could turn to him/her for advice if I were having 
problems.  
        
I feel I lack emotional closeness with him/her.          
 
 
 
Perceived Equity of Support 
25. The next question is about the give-and-take that goes on in the relationship 
between you and the person you came in with today. We want you to judge 
the give-and-take (for instance doing things for each other, listening to each 
other, and talking about each other’s problems) in your relationship. 
1. When you look at your relationship with the person you came in with today 
from a viewpoint of give-and-take, how would you describe your relationship? 
Please check one option. 
 He/she is doing a lot less for me than I am doing for him/her   
 He/she is doing somewhat less for me that I am doing for him/her   
 He/she is doing as much for me as I am doing for him/her    
 He/she is doing somewhat more for me than I am doing for him/her  
 He/she is doing a lot more for me than I am doing for him/her  
Thank you for your honest responses. We appreciate your participation in the 
survey. At this time, please inform the interviewer that you are ready for the next 
portion of the study. 
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Washington, D.C.. 
9. Wendorf, A. R., Jardas, J.R., Moore, E.M., Bilkey, S.T., Mosack, K.E. 
(November, 2010). Triggers for depressed mood in a diverse sample of HIV-
positive patients with comorbid depressive disorders. Poster presented at the 2010 
Association for Behavioral and Cognitive Therapies annual conference in San 
Francisco, California. 
10. Brouwer, A.M., Wendorf, A.R., Bilkey, S. & Mosack, K. E. (August, 2010). 
New Perspectives in predicting diabetes self-care behaviors: The Self-As-Doer. 
Poster presented at the 2010 American Psychological Association annual 
conference in San Diego, California. 
11. Brouwer, A.M., Wendorf, A.R., & Mosack, K.E. (April, 2010). Psychosocial 
differences in Type 1 and Type 2 Diabetes: The Self-As-Doer. Poster presented at 
the 2010 Society of Behavioral Medicine meeting, Seattle, WA. 
12. Brouwer, A.M., Wendorf, A.R., Espil, F.M., Sokolova, L., & Kucheras, S. 
(April, 2010). Exploring cultural themes in missing data: A survey project 
examining correlates of hypertension among Russian-Speaking immigrant 
women. Poster presented at the 2010 Society of Behavioral Medicine meeting, 
Seattle, WA.  Awarded the Student Meritorious Abstract Award and the Ethnic 
Minority and Multicultural Special Interest Group Student Abstract Award. 
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13. Brouwer, A.M., Wendorf, A.R., Espil, F.M., & Mosack, K.E. (August, 2009). 
Hypertension in Older Russian Immigrant Women: Complementary Therapy 
Usage and Acculturation. Poster presented at the annual APA conference, 
Toronto, Ontario, Canada. 
14. Wendorf, A.R., Brouwer, A.M., Espil, F.M., & Mosack, K.E. (May, 2009). 
Depression and adherence: Hypertension in older Russian immigrant women. 
Poster presented at the annual APS conference, San Francisco, CA. 
15. Brouwer, A.M., Wendorf, A.R., & Mosack, K.E. (May, 2009). Hypertension in 
older Russian immigrant women: Cultural identity and illness beliefs. Poster 
presented at the annual APS conference, San Francisco, CA. 
16. Wendorf, A.R. & Mosack, K.E. (September, 2008). Medical providers’ 
perspectives on family involvement in HIV treatment: Benefits, disadvantages, 
and challenges. Poster presented at the annual 2008 joint British Psychological 
Society Division of Health Psychology and European Health Psychology Society 
Conference, Bath, England. 
17. Walther, M.R., Levine, J. C., Conolea, C. A., Wendorf,  A. R., & J. Kanter 
(November, 2008). Validation of the Polaris Outcome Assessment in a CBT 
Training Clinic. Poster presented at the ABCT annual conference, Orlando, FL.    
18. Wendorf, A.R. & Reddy, D.M. (May, 2008).  Increased academic success and 
retention in psychology through online instruction. Poster presented at the APS 
annual conference, Chicago, IL 
19. Ports, K.A., Li-Barber, K.T., Fine, K.M., Wendorf, A.R., Helion, A.M., 
Andresen, E.N., Fleming, R., & Reddy, D.M.  (May, 2008). Increasing student 
success: Results from the University of Wisconsin-Milwaukee’s U-Pace 
Initiative. Poster presented at the APS annual conference, Chicago, IL. 
20. Roethel (Wendorf), A.J. (August, 2007). Effectiveness of stress management 
techniques: Psychological and physiological indicators. Poster presented at APA 
annual conference, San Francisco, CA. 
 
Invited Community Talks 
1. Moore, K.M., Petrik, M., & Wendorf, A.R. (March, 2011). Psychological 
experiences following bariatric surgery. Presented at a meeting of the Froedtert 
Hospital Post-Bariatric Surgery Support Group on March 28, 2011 in Wauwatosa, 
WI. 
2. Valvano, A., Moore, K.M., Wendorf, A.R., & Wilson, A. (March, 2011). Mental 
health issues post-transplant. Presented at a meeting of the Froedtert Hospital 
Post-Abdominal Transplant Support Group on March 1, 2011.  
3. Roethel (Wendorf), A.J. (2006). Stress management: A high school survival 
guide. Presented at Michicot High School, Michicot, WI for the freshmen 
workshop series. 
_____________________________________________________________________ 
CLINICAL EXPERIENCE  
Internship in Clinical Psychology (APA-accredited)     
    8/26/2013-8/22/2014 
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Veterans Affairs Palo Alto Health Care System, Behavioral Medicine Track 
Current Rotations:  
 Behavioral Medicine: Assessment, consultation, and  intervention with 
veterans who are medical or surgical patients 
o Behavioral Medicine Clinic: Responsibilities include assessment and 
intervention with veterans referred for behavioral problems related to 
illness; treatment of anxiety, depression, or other mental health 
conditions related to medical problems 
o Hepatitis C Clinic: Responsibilities include assessment of veterans 
who are being considered for antiviral treatment of HCV and 
intervention for those who are currently on treatment; work within an 
interdisciplinary team 
o Hematology/Oncology Clinics: Responsibilities include assessment 
and intervention for patients with hematological or oncological 
disorders/disease; consultation/liaison; coordination and integration 
with multidisciplinary teams 
 Inpatient Spinal Cord Injury Unit: Responsibilties include conducting 
evaluations and interventions with patients eith spinal cord injuries; conduct 
screening of cognitive assessment and administer neuropsychological tests; 
provide care within well-integrated interdisciplinary team within the 
rehabilitation setting 
 Upcoming Rotations (02/21/2014-08/22/2014):  
o Infectious Disease/HIV clinic, Smoking Cessation, MOVE TIME 
(weight loss intervention and bariatric clinic) First Step (90 Day 
Residential Substance Abuse Rehabilitation Program), Acceptance and 
Commitment Therapy Mini Rotation 
 
Health Psychology Practicum Student (Extern)                                
5/2012-12/2012 
Medical College of Wisconsin/Froedtert Hospital, Wauwatosa, WI 
 Training in clinical health psychology/behavioral medicine within the 
Department of Transplant Surgery  
o Responsibilities include conducting psychological evaluations and 
follow-up for potential lung transplant candidates (d/t cystic fibrosis, 
chronic obstructive pulmonary disease, emphysema); providing 
inpatient consultation and interventions to hospitalized transplant 
candidates; and consulting with the transplant medical team 
  Supervisor: Rebecca C. Anderson, Ph.D. 
 
Health Psychology Practicum Student (Extern)                         
09/2011-8/27/2012 
University of Wisconsin Hospitals and Clinics, Department of Orthopedics and 
Rehabilitation, Madison, WI 
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 Training in clinical health psychology/behavioral medicine within a physical 
rehabilitation department.  
o Responsibilities included providing psychological services such as 
intake assessments, individual therapy, and group therapy to medical 
outpatients in an outpatient health psychology department. Facilitated 
support groups for patients coping with various chronic illnesses (e.g., 
neurological disorders, pulmonary disorders, diabetes, obesity, 
fibromyalgia, tinnitus). Created program curricula for new 
psychotherapy groups for patients with medical illnesses.  
o Interventions included cognitive behavioral therapy, behavioral 
activation for depression, acceptance and commitment therapy, and 
cognitive-behavioral stress management.  
 Supervisor: Heidi Beckman, Ph.D. 
 
Health Psychology Practicum Student (Extern)                             
06/2010-08/2011 
Medical College of Wisconsin/Froedtert Hospital, Wauwatosa, WI 
 Department of Trauma and Critical Care Surgery 
o Responsibilities included consultation/liaison with members of the 
medical trauma team and providing psychoeducation and individual 
cognitive-behavioral therapy to inpatients in a Level I trauma center. 
Other responsibilities included screening for mental status, acute stress 
disorder, and administering behavioral medicine-focused assessments 
to medical inpatients who experienced traumatic events and medical 
injuries.  
o Supervisor: Terri deRoon-Cassini, Ph.D. 
 Department of Transplant Surgery 
o Responsibilities included providing individual cognitive-behavioral 
therapy to adult outpatients and medical inpatients awaiting or 
adjusting to liver, kidney, pancreas, or lung transplants; conducting 
psychological evaluations for potential liver, kidney, and pancreas 
transplant candidates; conducting psychological evaluations for living 
kidney donors; co-facilitating support groups for patients awaiting 
kidney transplants; co-facilitating support groups for patients who 
have received liver, kidney, and pancreas transplants; and consultation 
with the transplant medical team. Other responsibilities included 
administering diagnostic and behavioral medicine focused assessments 
to potential transplant candidates and living donors, providing follow-
up on assessment results and the treatment plan for transplant 
candidacy, and report writing. 
o Supervisor: Rebecca C. Anderson, Ph.D. 
 Departments of General Surgery and Plastic and Reconstructive Surgery 
o Responsibilities included providing individual therapy for medical 
patients with posttraumatic stress disorder, and health and behavior 
interventions to adult clients with comorbid medical illness (e.g., 
diabetes, morbid obesity, chronic pain, Crohn’s disease, ulcerative 
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colitis, non-epileptic seizures), conducting psychological evaluations 
and health behavior interventions for potential bariatric surgery 
candidates, and collaboration with the outpatient medical teams.  
o Interventions included cognitive behavioral therapy, Behavioral 
Activation for Depression, and Cognitive Processing Therapy 
o Supervisor: Mark Rusch, Ph.D.  
 
Graduate Student Therapist                                   
05/2009-5/2013  
Practicum in Therapy, Psychology Clinic, University of Wisconsin-Milwaukee, 
Milwaukee, WI  
 Training in adult and child outpatient therapy. Responsibilities include 
providing individual therapy to adult, adolescent, and child clients. Presenting 
concerns include mood disorders, insomnia, adjustment disorders, and social 
skills deficits. Interventions include: Behavioral Activation for Depression, 
Acceptance and Commitment Therapy, Dialectical Behavior Therapy Skills 
Training (individual format), CBT for Insomnia, and Affirmative Counseling. 
Additional responsibilities include administering assessment measures to 
potential clients.  
Supervisors: Gwynne O. Kohl, Ph.D.; Jonathan W. Kanter, Ph.D.  
 
Clinical Psychology Practicum Student                                  
9/2007-5/2009 
Psychology Clinic, University of Wisconsin-Milwaukee, Milwaukee, WI  
 Training in clinical interviewing, scoring, and report writing. Received 
training in empirically supported treatments for DSM-IV diagnoses.  
 Received training in administration of psychological and neuropsychological 
assessment instruments for adults, clinical interviewing, scoring, and report 
writing. 
 Training in the administration of child assessment instruments and projective 
instruments, clinical interviews, assessment scoring, integrative report writing, 
and classroom observation; emphasis on cultural and ethnic diversity. 
Provided assessment services and consultation to an Individualized Education 
Plan team at a local charter school 
 
TEACHING EXPERIENCE 
Project Assistant, Undergraduate Research Apprenticeship Program in Psychology, 
UW-Milwaukee. 7/2008-6/2011.  
 Developed and led structured discussions on topics related to research and 
professional development in psychology for undergraduate research assistants, 
facilitated interactive group discussion and presentation of research, answered 
questions, mentored and advised students 
Teaching Assistant, Introductory Psychology UPace, UW-Milwaukee, 9/07-5/08,  
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 Facilitated web based instruction, monitored and provided individualized 
feedback on student progress in the online course, advised students, provided 
assistance with course material via email or face to face discussions, served as 
student-professor liaison 
Teaching Assistant, Introductory Psychology, UW-Green Bay, 9/06-12/06,  
 Developed and led exam review sessions, presented a lecture, served as a student-
professor liaison 
Study group leader, Introductory Psychology, UW-Green Bay, 9/06-12/06 
 Developed and led structured discussions, answered questions, reviewed course 
material, and helped students prepare for exams on a weekly basis 
________________________________________________________________________ 
PROFESSIONAL AFFILIATIONS 
American Psychological Association (APA) 
Member of Division 38 and 45 
Association for Behavioral and Cognitive Therapies (ABCT) 
Member of Behavioral Medicine Special Interest Group 
Society of Behavioral Medicine (SBM) 
______________________________________________________________________ 
PROFESSIONAL ACTIVITIES 
National Organization Leadership 
 Graduate Student Chair, Educational and Training Council, Health Psychology 
(Div. 38, 2009-5/2012) 
 Member, Behavioral Medicine Program Committee (ABCT, 2009-2010) 
 
University Leadership 
 Student Representative, Clinical Training Committee, UWM Clinical Psychology 
Program (May 2012-May 2013) 
 Grant Committee, Association for Graduate Students in Psychology (9/2007-
5/2013) 
 Grant Committee, Health Psychology Graduate Student Club (9/2008-5/2013) 
 
 
 
